data_1agg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1agg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.525 0.679 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.583 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p . . . . . 0 CA--C 1.567 1.618 0 CA-C-O 121.321 0.581 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p . . . . . 0 CA--C 1.567 1.616 0 CA-C-O 121.604 0.716 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.566 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p . . . . . 0 CA--C 1.567 1.602 0 CA-C-O 121.817 0.818 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.557 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p . . . . . 0 CA--C 1.571 1.777 0 CA-C-O 122.156 0.979 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.618 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.587 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.587 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HG2' ' HG1' ' A' ' 37' ' ' THR . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 32' ' ' THR . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 30' ' ' ILE . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.442 ' HG1' ' HG2' ' A' ' 24' ' ' PRO . 10.8 p . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 121.048 0.451 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.749 ' HG ' ' H ' ' A' ' 29' ' ' MET . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.749 ' H ' ' HG ' ' A' ' 28' ' ' SER . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p . . . . . 0 CA--C 1.571 1.765 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 36' ' ' CYS . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.655 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.477 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.954 0.883 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' HG1' ' A' ' 37' ' ' THR . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.541 ' HG1' ' HA ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 29' ' ' MET . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.7 ' H ' ' HG ' ' A' ' 28' ' ' SER . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p . . . . . 0 CA--C 1.569 1.694 0 CA-C-O 121.558 0.694 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.466 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.581 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.497 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p . . . . . 0 CA--C 1.568 1.667 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.629 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.657 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.657 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.437 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.54 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.635 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 121.603 0.716 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.616 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.616 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p . . . . . 0 CA--C 1.57 1.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.609 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' HE1' ' A' ' 14' ' ' TRP . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 33' ' ' ASN . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 32' ' ' THR . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 121.783 0.801 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.483 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 29' ' ' MET . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.709 ' H ' ' HG ' ' A' ' 28' ' ' SER . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 122.127 0.965 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.628 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p . . . . . 0 CA--C 1.569 1.681 0 CA-C-O 121.348 0.594 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.573 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 CA--C 1.554 1.125 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.04 115.28 21.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -173.9 87.94 0.06 Allowed 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 124.885 2.279 . . . . 0.0 105.38 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p -139.26 170.87 15.17 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 110.989 -2.823 . . . . 0.0 110.49 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p -140.85 138.27 18.06 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.68 -52.87 0.87 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 123.185 2.59 . . . . 0.0 114.753 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -155.37 128.79 8.38 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.25 122.48 47.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.03 132.55 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.2 tpp 65.13 96.7 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 126.242 1.817 . . . . 0.0 108.595 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.23 129.53 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.938 2.095 . . . . 0.0 109.104 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.63 -109.42 2.49 Favored Glycine 0 N--CA 1.479 1.554 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.1 mt 67.31 151.61 0.07 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.359 1.863 . . . . 0.0 111.709 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.7 p -70.98 126.52 29.8 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.279 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 t80 59.96 91.73 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.248 1.819 . . . . 0.0 109.94 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 122.627 1.203 . . . . 0.0 108.631 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.559 1.32 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.46 136.99 32.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.508 0.723 . . . . 0.0 109.96 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 61.37 23.27 13.54 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 125.954 1.702 . . . . 0.0 115.581 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p -96.23 173.76 7.23 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.65 1.18 . . . . 0.0 112.092 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.583 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p -141.18 146.6 43.69 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -63.9 164.85 20.46 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 123.57 2.847 . . . . 0.0 114.434 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.39 125.12 28.63 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.007 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.94 114.31 21.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.9 106.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -124.82 90.48 3.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.424 1.107 . . . . 0.0 108.926 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.66 63.37 1.77 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 114.343 -1.299 . . . . 0.0 115.392 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -154.58 -73.25 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.3 t -108.01 86.73 2.35 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 162.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -154.91 130.32 9.76 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 122.69 1.233 . . . . 0.0 110.292 169.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.71 -73.25 0.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -90.9 -73.74 0.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.869 0.842 . . . . 0.0 109.53 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p -119.18 170.43 9.09 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.299 169.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -102.93 146.15 31.87 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.35 144.75 51.76 Favored 'Trans proline' 0 CA--C 1.558 1.717 0 C-N-CA 124.312 3.341 . . . . 0.0 114.264 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -78.59 129.61 34.98 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.922 0.868 . . . . 0.0 109.951 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.17 154.58 46.99 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.981 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -82.62 128.86 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-O 121.918 0.866 . . . . 0.0 108.87 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.4 ttt -96.58 137.43 35.67 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.933 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.61 131.0 38.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.575 1.179 . . . . 0.0 110.039 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.34 103.71 0.25 Allowed Glycine 0 N--CA 1.478 1.455 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt 81.24 128.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 126.258 1.823 . . . . 0.0 106.104 -151.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.9 p -70.36 117.4 11.86 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.349 0.595 . . . . 0.0 111.056 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.37 -65.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.181 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.658 1.218 . . . . 0.0 110.292 175.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.668 0.747 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.8 119.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.697 1.999 . . . . 0.0 109.777 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.1 22.84 12.08 Favored 'General case' 0 N--CA 1.517 2.92 0 C-N-CA 126.373 1.869 . . . . 0.0 115.79 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p -148.02 172.82 13.63 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.764 1.225 . . . . 0.0 110.731 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.566 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t -136.77 138.89 27.43 Favored Pre-proline 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.63 124.39 8.78 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.952 3.101 . . . . 0.0 112.686 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -120.2 -90.86 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.33 102.67 4.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -76.01 132.08 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.244 1.021 . . . . 0.0 109.182 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.8 mtp -90.22 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.864 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 72.12 127.44 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.014 2.126 . . . . 0.0 109.136 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.52 -83.4 0.08 OUTLIER Glycine 0 N--CA 1.481 1.665 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.059 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.23 89.56 3.11 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 160.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.7 t -143.94 -74.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 63.64 92.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 126.474 1.91 . . . . 0.0 110.333 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 122.59 1.186 . . . . 0.0 108.796 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.81 -63.42 1.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.801 0.841 . . . . 0.0 109.472 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 m120 59.51 21.32 9.81 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 126.394 1.878 . . . . 0.0 115.742 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p -147.64 169.38 19.77 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 125.044 1.338 . . . . 0.0 110.503 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.557 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p -137.03 131.03 17.72 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.73 -78.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 123.215 2.61 . . . . 0.0 112.596 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -139.15 -52.98 0.56 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.136 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp 73.63 -79.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 127.592 2.357 . . . . 0.0 108.248 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.8 mm 68.29 93.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 126.581 1.952 . . . . 0.0 106.423 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.71 153.3 51.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.793 0.806 . . . . 0.0 110.02 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 71.95 137.53 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 126.808 2.043 . . . . 0.0 109.539 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.2 -74.58 0.61 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.273 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.66 104.3 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 p -127.23 96.2 4.51 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -98.6 -67.11 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.102 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 124.553 2.121 . . . . 0.0 110.24 -173.695 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.559 1.295 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -96.34 126.01 41.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.841 0.746 . . . . 0.0 109.04 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -73.48 -33.14 64.69 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p 67.86 162.11 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 129.058 2.943 . . . . 0.0 110.957 -169.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.618 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.587 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.587 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HG2' ' HG1' ' A' ' 37' ' ' THR . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 32' ' ' THR . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 30' ' ' ILE . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.442 ' HG1' ' HG2' ' A' ' 24' ' ' PRO . 10.8 p -128.35 132.42 24.34 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -41.77 -65.01 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 124.878 3.718 . . . . 0.0 116.429 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -155.3 -78.05 0.09 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.683 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp 68.39 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 126.515 1.926 . . . . 0.0 107.109 -169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -121.4 131.51 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 158.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 ttp -79.92 122.63 26.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.724 -0.61 . . . . 0.0 109.989 -172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.06 112.27 12.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.71 -85.87 0.08 OUTLIER Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp 57.75 85.69 0.08 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.322 1.849 . . . . 0.0 110.799 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 p -160.82 104.24 1.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.9 t80 62.59 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.781 1.633 . . . . 0.0 108.912 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 124.6 2.143 . . . . 0.0 111.952 177.737 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.04 95.69 7.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 177.94 91.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p -140.1 171.19 14.53 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 111.441 -2.618 . . . . 0.0 110.765 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.749 ' HG ' ' H ' ' A' ' 29' ' ' MET . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.749 ' H ' ' HG ' ' A' ' 28' ' ' SER . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p -110.93 123.28 35.8 Favored Pre-proline 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -84.04 147.97 11.88 Favored 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.271 2.648 . . . . 0.0 114.263 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -84.23 -62.45 1.56 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.1 tp -106.81 -89.63 0.44 Allowed 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.19 132.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -138.75 81.94 1.87 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 60.48 120.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 126.949 2.099 . . . . 0.0 112.07 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.77 81.11 0.17 Allowed Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.869 -1.514 . . . . 0.0 115.508 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.3 tp -94.33 105.09 17.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.2 p -109.29 79.87 1.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.967 0.889 . . . . 0.0 108.863 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -89.04 -65.29 1.03 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.808 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 122.618 1.199 . . . . 0.0 110.353 -178.801 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -108.61 116.72 32.5 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 m120 60.06 80.16 0.21 Allowed 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 125.157 2.408 . . . . 0.0 108.664 -173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p -53.78 167.45 0.25 Allowed 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 109.25 -3.613 . . . . 0.0 115.953 -168.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 36' ' ' CYS . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.655 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.655 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.477 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p -28.92 165.33 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.77 151.4 68.97 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 124.79 3.66 . . . . 0.0 113.491 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -70.59 152.73 43.61 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.389 0.614 . . . . 0.0 111.273 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.06 147.09 40.52 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.892 0.877 . . . . 0.0 112.594 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.5 mm 76.8 130.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -157.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -59.95 132.98 55.63 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.817 0.847 . . . . 0.0 111.917 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 73.9 142.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.592 1.957 . . . . 0.0 108.677 -163.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.27 103.49 0.48 Allowed Glycine 0 CA--C 1.547 2.044 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 tt -142.73 -58.32 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.646 0.778 . . . . 0.0 109.707 -164.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t 69.62 99.62 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 127.01 2.124 . . . . 0.0 109.538 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 65.51 107.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.278 1.831 . . . . 0.0 110.32 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 122.561 1.172 . . . . 0.0 109.943 179.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -105.49 62.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.841 0.829 . . . . 0.0 110.762 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 177.66 91.02 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p -156.14 172.97 17.51 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 112.11 -2.314 . . . . 0.0 111.507 -169.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' HG1' ' A' ' 37' ' ' THR . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.541 ' HG1' ' HA ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER -35.39 166.18 0.03 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.7 153.23 78.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 125.223 3.948 . . . . 0.0 113.47 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -58.64 118.1 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.149 0.976 . . . . 0.0 112.477 -169.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.7 tp -146.38 152.01 38.39 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.106 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.21 105.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 122.575 1.179 . . . . 0.0 110.86 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 mtt -154.56 112.27 3.45 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 65.91 159.57 0.12 Allowed 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 125.782 1.633 . . . . 0.0 112.465 168.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.59 81.92 1.34 Allowed Glycine 0 N--CA 1.483 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 111.124 162.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.41 -80.6 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -106.72 80.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.524 1.057 . . . . 0.0 108.15 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.9 t80 57.5 -95.94 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.345 1.858 . . . . 0.0 109.097 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 120.098 1.317 . . . . 0.0 107.757 170.537 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.63 106.13 10.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -74.21 -41.33 61.55 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -148.33 162.59 39.22 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.595 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 29' ' ' MET . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.7 ' H ' ' HG ' ' A' ' 28' ' ' SER . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p -97.37 120.94 59.91 Favored Pre-proline 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.64 28.24 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.157 2.571 . . . . 0.0 116.535 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 49.69 41.08 21.33 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 125.884 1.674 . . . . 0.0 113.505 -170.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.3 mt -151.32 -66.33 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.12 0.968 . . . . 0.0 108.41 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 pt -135.26 109.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.403 0.681 . . . . 0.0 110.783 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 66.6 134.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.977 2.111 . . . . 0.0 110.62 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.96 110.61 0.23 Allowed Glycine 0 N--CA 1.478 1.455 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.716 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -118.93 169.11 10.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.951 0.882 . . . . 0.0 111.682 -170.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.3 m 70.52 107.86 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 126.703 2.001 . . . . 0.0 109.614 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -141.3 115.59 9.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.241 1.972 . . . . 0.0 109.614 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.11 -73.29 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.11 80.03 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 126.124 2.868 . . . . 0.0 106.363 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p -157.83 176.84 12.05 Favored 'General case' 0 CA--C 1.569 1.694 1 CA-C-N 107.541 -4.39 . . . . 0.0 110.193 -169.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.466 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.581 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -150.86 136.83 10.85 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.89 127.52 8.66 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.683 2.922 . . . . 0.0 112.184 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -86.49 97.32 10.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.873 0.844 . . . . 0.0 109.471 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.96 -69.52 0.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.17 128.3 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.779 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 123.21 23.59 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.57 0.7 . . . . 0.0 109.862 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -132.45 155.76 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.015 0.912 . . . . 0.0 110.753 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.86 -152.48 6.51 Favored Glycine 0 CA--C 1.547 2.067 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.6 tp 59.41 88.79 0.07 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.953 1.701 . . . . 0.0 109.069 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.645 ' HG ' ' H ' ' A' ' 47' ' ' PHE . 49.7 p -138.91 -77.84 0.35 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.508 -160.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.645 ' H ' ' HG ' ' A' ' 46' ' ' SER . 9.8 t80 -160.85 124.97 3.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.844 1.202 . . . . 0.0 108.25 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.237 1.97 . . . . 0.0 108.648 169.165 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.34 -62.33 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.794 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 m120 60.32 18.18 7.78 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 126.403 1.881 . . . . 0.0 116.01 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.49 167.66 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 128.354 2.662 . . . . 0.0 112.992 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.497 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -136.68 138.05 25.32 Favored Pre-proline 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.01 133.23 12.22 Favored 'Trans proline' 0 CA--C 1.561 1.831 0 C-N-CA 123.571 2.847 . . . . 0.0 113.415 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -101.02 2.7 40.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -141.47 -75.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 122.247 2.294 . . . . 0.0 108.567 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.22 120.63 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 ptp -72.81 135.52 45.24 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.531 0.681 . . . . 0.0 111.138 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.13 50.78 17.02 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.908 1.683 . . . . 0.0 113.54 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.99 90.82 0.11 Allowed Glycine 0 N--CA 1.479 1.502 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.808 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.44 145.95 28.69 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.095 0.558 . . . . 0.0 110.396 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.3 p -67.99 -51.22 49.75 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.532 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -100.75 95.57 6.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 122.485 1.136 . . . . 0.0 110.727 -170.463 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.85 99.97 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.571 1.948 . . . . 0.0 110.394 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.5 t30 58.67 85.38 0.09 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 125.311 2.481 . . . . 0.0 107.848 -170.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p -68.24 171.68 6.82 Favored 'General case' 0 CA--C 1.568 1.667 1 CA-C-N 107.513 -4.403 . . . . 0.0 115.514 -168.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.629 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.657 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.657 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.437 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.04 145.83 31.6 Favored Pre-proline 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.91 155.98 1.52 Allowed 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 124.467 3.444 . . . . 0.0 115.864 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -70.26 129.26 38.87 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.414 0.626 . . . . 0.0 111.503 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -105.91 88.49 2.82 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.3 tt -94.24 127.27 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -165.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.31 -62.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.685 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 72.96 132.64 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 126.932 2.093 . . . . 0.0 110.047 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.0 82.63 0.06 OUTLIER Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.619 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -145.37 93.31 2.35 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t 64.82 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 126.332 1.853 . . . . 0.0 108.956 -165.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -81.17 143.96 31.99 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.363 0.983 . . . . 0.0 110.462 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.586 2.136 . . . . 0.0 108.653 171.774 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.6 92.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.05 1.74 . . . . 0.0 110.329 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.77 18.54 11.2 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.316 1.846 . . . . 0.0 115.88 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p -133.16 176.36 8.57 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 169.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p -103.41 113.86 65.35 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.67 -37.17 70.69 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.837 3.025 . . . . 0.0 117.21 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 40.56 68.63 0.39 Allowed 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.976 2.11 . . . . 0.0 112.939 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.51 -39.89 15.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.047 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.7 mm 67.17 93.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 126.562 1.945 . . . . 0.0 107.926 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.0 ttm 61.98 -94.33 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 126.549 1.939 . . . . 0.0 110.109 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 70.92 134.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.115 2.166 . . . . 0.0 110.075 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.89 96.63 1.43 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.932 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -22.09 61.41 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.6 p -91.54 108.21 19.74 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.891 1.678 . . . . 0.0 108.187 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -99.39 -66.32 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.719 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.121 1.915 . . . . 0.0 109.543 178.701 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.0 -65.44 1.02 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -149.87 75.35 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 126.266 2.936 . . . . 0.0 107.133 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p -160.07 165.27 32.14 Favored 'General case' 0 CA--C 1.567 1.621 1 CA-C-N 107.628 -4.351 . . . . 0.0 109.987 172.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.54 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.94 165.95 0.13 Allowed Pre-proline 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.39 168.93 18.18 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.779 3.653 . . . . 0.0 115.272 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -90.71 81.53 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.8 tp -173.1 114.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.1 69.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 123.064 1.412 . . . . 0.0 108.206 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 ttt -165.69 90.5 0.47 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -139.89 141.7 36.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.913 0.863 . . . . 0.0 109.604 -162.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.72 -77.31 0.84 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.925 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.61 104.44 12.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.2 p -151.85 116.52 5.12 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.498 0.666 . . . . 0.0 109.557 -166.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -153.27 139.5 18.43 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HA ' ' H ' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 124.577 2.132 . . . . 0.0 109.07 173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -103.21 108.2 19.32 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 179.04 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p -144.02 170.63 15.56 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 111.607 -2.542 . . . . 0.0 111.123 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.635 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.635 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -87.14 122.83 70.84 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' HA ' ' HD2' ' A' ' 8' ' ' ASP . 47.4 Cg_exo -51.63 -59.98 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.037 3.158 . . . . 0.0 115.344 172.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 49.86 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 128.805 2.842 . . . . 0.0 114.744 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 tt 69.56 104.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 126.382 1.873 . . . . 0.0 109.477 169.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.11 135.05 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 ttt -86.49 108.08 18.37 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.51 131.0 57.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.49 81.31 1.33 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.762 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mp -93.75 -69.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -91.77 -69.08 0.76 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -149.18 106.86 3.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 124.304 2.002 . . . . 0.0 108.371 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 121.658 0.742 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.0 82.58 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.74 19.99 4.78 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.97 169.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 C-N-CA 128.167 2.587 . . . . 0.0 112.854 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -144.03 138.51 15.07 Favored Pre-proline 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.28 161.69 34.7 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.372 2.715 . . . . 0.0 113.549 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.54 107.41 6.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 79.94 114.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -88.46 103.48 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -160.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 tpt -154.65 111.19 3.27 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -95.68 133.71 39.45 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.068 0.937 . . . . 0.0 109.276 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.65 -107.85 1.07 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.178 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.98 -64.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.024 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.2 p -79.93 135.84 36.51 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.463 0.705 . . . . 0.0 110.423 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -76.69 -75.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 117.747 -1.12 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.615 1.197 . . . . 0.0 110.889 179.196 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.81 111.43 5.73 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 58.2 23.28 10.1 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p -142.73 176.93 8.67 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.391 1.077 . . . . 0.0 110.998 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.616 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.616 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p -94.13 121.52 63.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -48.84 -54.42 5.43 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.916 3.078 . . . . 0.0 115.055 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -152.32 -76.5 0.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.84 132.2 54.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pp -91.23 98.01 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.12 127.27 10.5 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -98.37 131.27 44.8 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.43 80.85 1.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.405 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.7 tp 61.26 -97.47 0.07 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.277 1.831 . . . . 0.0 110.038 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 134.79 14.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.338 1.426 . . . . 0.0 109.243 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -138.35 113.46 9.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.618 1.199 . . . . 0.0 110.535 -179.213 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -112.03 96.12 5.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.373 -1.344 . . . . 0.0 107.373 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 t30 175.78 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p -125.49 171.16 10.73 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 108.636 -3.893 . . . . 0.0 110.772 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.609 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -142.09 132.2 12.58 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.42 85.93 1.22 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.643 2.895 . . . . 0.0 112.331 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 63.02 113.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 126.385 1.874 . . . . 0.0 109.208 -169.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -78.11 128.23 33.5 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.5 pt -84.99 131.44 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.129 0.966 . . . . 0.0 108.801 -170.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.33 116.52 25.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -123.72 136.59 54.54 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.035 0.921 . . . . 0.0 109.116 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.477 1.414 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.27 90.24 5.78 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 167.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -131.43 68.98 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.918 0.866 . . . . 0.0 108.86 173.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.03 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.768 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.198 1.951 . . . . 0.0 108.606 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.651 ' HE2' ' HA ' ' A' ' 5' ' ' ILE . 13.3 mm-40 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.94 -57.97 0.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.577 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -137.73 9.18 2.85 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -147.05 169.51 19.1 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.393 1.077 . . . . 0.0 110.876 172.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' HA ' ' HE2' ' A' ' 1' ' ' GLU . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' HE1' ' A' ' 14' ' ' TRP . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 33' ' ' ASN . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 32' ' ' THR . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.4 140.77 17.06 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.5 73.15 5.26 Favored 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 123.396 2.731 . . . . 0.0 113.599 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 mtp-105 47.21 70.75 0.38 Allowed 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 125.923 1.689 . . . . 0.0 111.764 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.9 tp -157.38 108.62 2.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -88.57 124.27 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.4 ptm -102.95 100.17 10.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -152.27 136.83 16.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.88 99.69 2.56 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-N 114.57 -1.195 . . . . 0.0 112.523 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.37 127.92 10.76 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -94.33 -69.79 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.677 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -95.34 -67.07 0.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.57 0.748 . . . . 0.0 109.884 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 124.612 2.149 . . . . 0.0 110.331 -173.07 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.562 1.418 0 CA-C-O 122.178 0.989 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -140.22 -91.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 174.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -95.27 2.62 54.87 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 169.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p -159.06 165.86 32.96 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 125.843 1.657 . . . . 0.0 108.775 169.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p -103.77 121.61 47.51 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -52.84 157.38 7.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 124.607 3.538 . . . . 0.0 116.575 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -140.53 126.98 20.04 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 43.02 -157.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 127.467 2.307 . . . . 0.0 114.029 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm 74.04 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 C-N-CA 126.869 2.068 . . . . 0.0 107.546 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 ptm -114.2 165.71 12.39 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.408 1.099 . . . . 0.0 110.063 164.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.02 141.38 43.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.793 0.806 . . . . 0.0 110.831 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.32 -103.67 3.05 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.036 -175.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.1 mt -94.38 118.71 32.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.8 m -80.11 118.87 22.2 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.181 0.515 . . . . 0.0 110.608 -170.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -135.1 -75.66 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 124.118 1.914 . . . . 0.0 108.288 -178.112 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 CA--C 1.558 1.279 0 CA-C-O 118.345 -0.836 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.47 90.28 0.06 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.271 1.829 . . . . 0.0 109.555 -173.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -102.28 -77.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.763 0.792 . . . . 0.0 109.331 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p -125.09 174.13 8.25 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.972 172.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 29' ' ' MET . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.709 ' H ' ' HG ' ' A' ' 28' ' ' SER . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -144.44 136.52 13.13 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.06 88.49 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 123.963 3.109 . . . . 0.0 113.061 -176.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -90.35 123.24 33.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.768 -169.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.2 mt -72.92 -56.5 5.08 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.076 174.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.81 111.03 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 163.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.6 ttt -64.16 -41.23 97.23 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.22 134.15 44.22 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.047 0.84 . . . . 0.0 110.766 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.23 -153.38 14.37 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 122.128 0.849 . . . . 0.0 112.616 178.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.7 tp -147.81 -70.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -103.12 91.35 4.07 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -139.91 125.53 19.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 122.42 1.105 . . . . 0.0 110.601 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -133.41 121.66 22.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 171.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -100.19 17.26 21.72 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p -141.56 169.41 17.66 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 124.825 1.25 . . . . 0.0 110.487 172.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.628 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -128.15 129.03 23.69 Favored Pre-proline 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.56 102.42 1.4 Allowed 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.138 2.559 . . . . 0.0 112.454 -171.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -101.04 88.35 3.5 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 83.25 2.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 169.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.4 pt 34.84 69.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 C-N-CA 126.977 2.111 . . . . 0.0 111.825 -158.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 52.0 mtt -127.9 89.05 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -167.86 149.29 5.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.865 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.55 -77.88 0.59 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.965 169.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -143.18 116.05 8.79 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m 67.84 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.497 1.919 . . . . 0.0 110.243 174.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -152.42 129.53 11.13 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.133 1.921 . . . . 0.0 108.951 170.07 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.95 87.33 0.09 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 126.078 1.751 . . . . 0.0 110.072 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 179.17 92.95 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 171.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p -111.33 176.24 5.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 111.788 -2.46 . . . . 0.0 111.66 -171.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.573 ' HG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HG1' ' A' ' 13' ' ' THR . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -145.26 142.96 18.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.66 157.96 57.13 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.859 3.04 . . . . 0.0 114.009 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 73.33 127.28 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 126.306 1.842 . . . . 0.0 108.496 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.27 176.89 2.53 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 123.587 0.755 . . . . 0.0 112.405 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.2 pt -66.29 121.04 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.025 0.917 . . . . 0.0 110.094 -171.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 30.2 ttp -94.87 124.4 38.89 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -75.14 128.78 36.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.192 0.996 . . . . 0.0 108.657 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -85.44 0.39 Allowed Glycine 0 CA--C 1.54 1.614 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.12 -159.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.5 mt -125.78 102.18 7.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.8 m -86.63 126.3 34.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.878 0.471 . . . . 0.0 109.807 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 p90 43.7 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 127.014 2.126 . . . . 0.0 112.087 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 124.578 2.132 . . . . 0.0 110.612 -176.526 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.525 0.679 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.412 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.411 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p . . . . . 0 CA--C 1.567 1.618 0 CA-C-O 121.321 0.581 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p . . . . . 0 CA--C 1.567 1.616 0 CA-C-O 121.604 0.716 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.527 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p . . . . . 0 CA--C 1.567 1.602 0 CA-C-O 121.817 0.818 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p . . . . . 0 CA--C 1.571 1.777 0 CA-C-O 122.156 0.979 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.582 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.472 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 121.048 0.451 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB ' ' A' ' 17' ' ' THR . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB3' HG13 ' A' ' 5' ' ' ILE . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p . . . . . 0 CA--C 1.571 1.765 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.954 0.883 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p . . . . . 0 CA--C 1.569 1.694 0 CA-C-O 121.558 0.694 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.561 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.531 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 17' ' ' THR . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.593 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p . . . . . 0 CA--C 1.568 1.667 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG21 ' SG ' ' A' ' 36' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.655 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 23' ' ' ARG . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 121.603 0.716 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p . . . . . 0 CA--C 1.57 1.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.424 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' HB ' ' A' ' 17' ' ' THR . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 5' ' ' ILE . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.655 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 121.783 0.801 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 122.127 0.965 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.641 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p . . . . . 0 CA--C 1.569 1.681 0 CA-C-O 121.348 0.594 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 CA--C 1.554 1.125 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.04 115.28 21.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -173.9 87.94 0.06 Allowed 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 124.885 2.279 . . . . 0.0 105.38 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p -139.26 170.87 15.17 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 110.989 -2.823 . . . . 0.0 110.49 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.412 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p -140.85 138.27 18.06 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.68 -52.87 0.87 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 123.185 2.59 . . . . 0.0 114.753 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -155.37 128.79 8.38 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.25 122.48 47.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.03 132.55 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.2 tpp 65.13 96.7 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 126.242 1.817 . . . . 0.0 108.595 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.23 129.53 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.938 2.095 . . . . 0.0 109.104 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.63 -109.42 2.49 Favored Glycine 0 N--CA 1.479 1.554 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.1 mt 67.31 151.61 0.07 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.359 1.863 . . . . 0.0 111.709 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.7 p -70.98 126.52 29.8 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.279 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 t80 59.96 91.73 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.248 1.819 . . . . 0.0 109.94 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 122.627 1.203 . . . . 0.0 108.631 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.559 1.32 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.46 136.99 32.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.508 0.723 . . . . 0.0 109.96 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 61.37 23.27 13.54 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 125.954 1.702 . . . . 0.0 115.581 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p -96.23 173.76 7.23 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.65 1.18 . . . . 0.0 112.092 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.411 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p -141.18 146.6 43.69 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -63.9 164.85 20.46 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 123.57 2.847 . . . . 0.0 114.434 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.39 125.12 28.63 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.007 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.94 114.31 21.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.9 106.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -124.82 90.48 3.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.424 1.107 . . . . 0.0 108.926 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.66 63.37 1.77 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 114.343 -1.299 . . . . 0.0 115.392 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -154.58 -73.25 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.3 t -108.01 86.73 2.35 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 162.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -154.91 130.32 9.76 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 122.69 1.233 . . . . 0.0 110.292 169.796 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.71 -73.25 0.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -90.9 -73.74 0.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.869 0.842 . . . . 0.0 109.53 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p -119.18 170.43 9.09 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.299 169.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -102.93 146.15 31.87 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.35 144.75 51.76 Favored 'Trans proline' 0 CA--C 1.558 1.717 0 C-N-CA 124.312 3.341 . . . . 0.0 114.264 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -78.59 129.61 34.98 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.922 0.868 . . . . 0.0 109.951 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.17 154.58 46.99 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.981 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -82.62 128.86 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-O 121.918 0.866 . . . . 0.0 108.87 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.4 ttt -96.58 137.43 35.67 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.933 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.61 131.0 38.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.575 1.179 . . . . 0.0 110.039 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.34 103.71 0.25 Allowed Glycine 0 N--CA 1.478 1.455 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt 81.24 128.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 126.258 1.823 . . . . 0.0 106.104 -151.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.9 p -70.36 117.4 11.86 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.349 0.595 . . . . 0.0 111.056 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.37 -65.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.181 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.658 1.218 . . . . 0.0 110.292 175.164 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.668 0.747 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.8 119.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.697 1.999 . . . . 0.0 109.777 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.1 22.84 12.08 Favored 'General case' 0 N--CA 1.517 2.92 0 C-N-CA 126.373 1.869 . . . . 0.0 115.79 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p -148.02 172.82 13.63 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.764 1.225 . . . . 0.0 110.731 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.527 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t -136.77 138.89 27.43 Favored Pre-proline 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.63 124.39 8.78 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.952 3.101 . . . . 0.0 112.686 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -120.2 -90.86 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.33 102.67 4.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -76.01 132.08 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.244 1.021 . . . . 0.0 109.182 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.8 mtp -90.22 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.864 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 72.12 127.44 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.014 2.126 . . . . 0.0 109.136 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.52 -83.4 0.08 OUTLIER Glycine 0 N--CA 1.481 1.665 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.059 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.23 89.56 3.11 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 160.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.7 t -143.94 -74.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 63.64 92.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 126.474 1.91 . . . . 0.0 110.333 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 122.59 1.186 . . . . 0.0 108.796 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.81 -63.42 1.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.801 0.841 . . . . 0.0 109.472 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 m120 59.51 21.32 9.81 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 126.394 1.878 . . . . 0.0 115.742 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p -147.64 169.38 19.77 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 125.044 1.338 . . . . 0.0 110.503 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p -137.03 131.03 17.72 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.73 -78.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 123.215 2.61 . . . . 0.0 112.596 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -139.15 -52.98 0.56 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.136 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp 73.63 -79.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 127.592 2.357 . . . . 0.0 108.248 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.8 mm 68.29 93.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 126.581 1.952 . . . . 0.0 106.423 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.71 153.3 51.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.793 0.806 . . . . 0.0 110.02 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 71.95 137.53 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 126.808 2.043 . . . . 0.0 109.539 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.2 -74.58 0.61 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.273 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.66 104.3 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 p -127.23 96.2 4.51 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -98.6 -67.11 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.102 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 124.553 2.121 . . . . 0.0 110.24 -173.695 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.559 1.295 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -96.34 126.01 41.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.841 0.746 . . . . 0.0 109.04 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -73.48 -33.14 64.69 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p 67.86 162.11 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 129.058 2.943 . . . . 0.0 110.957 -169.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.582 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.472 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.8 p -128.35 132.42 24.34 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -41.77 -65.01 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 124.878 3.718 . . . . 0.0 116.429 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -155.3 -78.05 0.09 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.683 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp 68.39 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 126.515 1.926 . . . . 0.0 107.109 -169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -121.4 131.51 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 158.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 ttp -79.92 122.63 26.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.724 -0.61 . . . . 0.0 109.989 -172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.06 112.27 12.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.71 -85.87 0.08 OUTLIER Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp 57.75 85.69 0.08 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.322 1.849 . . . . 0.0 110.799 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 p -160.82 104.24 1.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.9 t80 62.59 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.781 1.633 . . . . 0.0 108.912 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 124.6 2.143 . . . . 0.0 111.952 177.737 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.04 95.69 7.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 177.94 91.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p -140.1 171.19 14.53 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 111.441 -2.618 . . . . 0.0 110.765 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB ' ' A' ' 17' ' ' THR . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB3' HG13 ' A' ' 5' ' ' ILE . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p -110.93 123.28 35.8 Favored Pre-proline 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -84.04 147.97 11.88 Favored 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.271 2.648 . . . . 0.0 114.263 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -84.23 -62.45 1.56 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.1 tp -106.81 -89.63 0.44 Allowed 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.19 132.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -138.75 81.94 1.87 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 60.48 120.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 126.949 2.099 . . . . 0.0 112.07 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.77 81.11 0.17 Allowed Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.869 -1.514 . . . . 0.0 115.508 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.3 tp -94.33 105.09 17.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.2 p -109.29 79.87 1.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.967 0.889 . . . . 0.0 108.863 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -89.04 -65.29 1.03 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.808 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 122.618 1.199 . . . . 0.0 110.353 -178.801 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -108.61 116.72 32.5 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 m120 60.06 80.16 0.21 Allowed 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 125.157 2.408 . . . . 0.0 108.664 -173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p -53.78 167.45 0.25 Allowed 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 109.25 -3.613 . . . . 0.0 115.953 -168.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p -28.92 165.33 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.77 151.4 68.97 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 124.79 3.66 . . . . 0.0 113.491 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -70.59 152.73 43.61 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.389 0.614 . . . . 0.0 111.273 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.06 147.09 40.52 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.892 0.877 . . . . 0.0 112.594 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.5 mm 76.8 130.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -157.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -59.95 132.98 55.63 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.817 0.847 . . . . 0.0 111.917 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 73.9 142.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.592 1.957 . . . . 0.0 108.677 -163.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.27 103.49 0.48 Allowed Glycine 0 CA--C 1.547 2.044 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 tt -142.73 -58.32 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.646 0.778 . . . . 0.0 109.707 -164.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t 69.62 99.62 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 127.01 2.124 . . . . 0.0 109.538 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 65.51 107.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.278 1.831 . . . . 0.0 110.32 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 122.561 1.172 . . . . 0.0 109.943 179.563 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -105.49 62.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.841 0.829 . . . . 0.0 110.762 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 177.66 91.02 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p -156.14 172.97 17.51 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 112.11 -2.314 . . . . 0.0 111.507 -169.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -35.39 166.18 0.03 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.7 153.23 78.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 125.223 3.948 . . . . 0.0 113.47 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -58.64 118.1 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.149 0.976 . . . . 0.0 112.477 -169.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.7 tp -146.38 152.01 38.39 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.106 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.21 105.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 122.575 1.179 . . . . 0.0 110.86 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 mtt -154.56 112.27 3.45 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 65.91 159.57 0.12 Allowed 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 125.782 1.633 . . . . 0.0 112.465 168.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.59 81.92 1.34 Allowed Glycine 0 N--CA 1.483 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 111.124 162.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.41 -80.6 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -106.72 80.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.524 1.057 . . . . 0.0 108.15 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.9 t80 57.5 -95.94 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.345 1.858 . . . . 0.0 109.097 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 120.098 1.317 . . . . 0.0 107.757 170.537 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.63 106.13 10.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -74.21 -41.33 61.55 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -148.33 162.59 39.22 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.595 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p -97.37 120.94 59.91 Favored Pre-proline 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.64 28.24 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.157 2.571 . . . . 0.0 116.535 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 49.69 41.08 21.33 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 125.884 1.674 . . . . 0.0 113.505 -170.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.3 mt -151.32 -66.33 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.12 0.968 . . . . 0.0 108.41 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 pt -135.26 109.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.403 0.681 . . . . 0.0 110.783 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 66.6 134.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.977 2.111 . . . . 0.0 110.62 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.96 110.61 0.23 Allowed Glycine 0 N--CA 1.478 1.455 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.716 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 45' ' ' LEU . 2.7 pt? -118.93 169.11 10.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.951 0.882 . . . . 0.0 111.682 -170.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.3 m 70.52 107.86 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 126.703 2.001 . . . . 0.0 109.614 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -141.3 115.59 9.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.241 1.972 . . . . 0.0 109.614 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.11 -73.29 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.11 80.03 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 126.124 2.868 . . . . 0.0 106.363 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p -157.83 176.84 12.05 Favored 'General case' 0 CA--C 1.569 1.694 1 CA-C-N 107.541 -4.39 . . . . 0.0 110.193 -169.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.561 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -150.86 136.83 10.85 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.89 127.52 8.66 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.683 2.922 . . . . 0.0 112.184 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -86.49 97.32 10.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.873 0.844 . . . . 0.0 109.471 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.96 -69.52 0.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.17 128.3 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.779 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 123.21 23.59 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.57 0.7 . . . . 0.0 109.862 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -132.45 155.76 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.015 0.912 . . . . 0.0 110.753 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.86 -152.48 6.51 Favored Glycine 0 CA--C 1.547 2.067 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.6 tp 59.41 88.79 0.07 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.953 1.701 . . . . 0.0 109.069 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 p -138.91 -77.84 0.35 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.508 -160.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -160.85 124.97 3.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.844 1.202 . . . . 0.0 108.25 -170.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.237 1.97 . . . . 0.0 108.648 169.165 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.34 -62.33 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.794 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 m120 60.32 18.18 7.78 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 126.403 1.881 . . . . 0.0 116.01 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.49 167.66 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 128.354 2.662 . . . . 0.0 112.992 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 17' ' ' THR . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.593 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -136.68 138.05 25.32 Favored Pre-proline 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.01 133.23 12.22 Favored 'Trans proline' 0 CA--C 1.561 1.831 0 C-N-CA 123.571 2.847 . . . . 0.0 113.415 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -101.02 2.7 40.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -141.47 -75.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 122.247 2.294 . . . . 0.0 108.567 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.22 120.63 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 ptp -72.81 135.52 45.24 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.531 0.681 . . . . 0.0 111.138 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.13 50.78 17.02 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.908 1.683 . . . . 0.0 113.54 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.99 90.82 0.11 Allowed Glycine 0 N--CA 1.479 1.502 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.808 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.44 145.95 28.69 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.095 0.558 . . . . 0.0 110.396 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.3 p -67.99 -51.22 49.75 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.532 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -100.75 95.57 6.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 122.485 1.136 . . . . 0.0 110.727 -170.463 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.85 99.97 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.571 1.948 . . . . 0.0 110.394 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.5 t30 58.67 85.38 0.09 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 125.311 2.481 . . . . 0.0 107.848 -170.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p -68.24 171.68 6.82 Favored 'General case' 0 CA--C 1.568 1.667 1 CA-C-N 107.513 -4.403 . . . . 0.0 115.514 -168.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG21 ' SG ' ' A' ' 36' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.04 145.83 31.6 Favored Pre-proline 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.91 155.98 1.52 Allowed 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 124.467 3.444 . . . . 0.0 115.864 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -70.26 129.26 38.87 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.414 0.626 . . . . 0.0 111.503 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -105.91 88.49 2.82 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.3 tt -94.24 127.27 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -165.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.31 -62.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.685 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 72.96 132.64 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 126.932 2.093 . . . . 0.0 110.047 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.0 82.63 0.06 OUTLIER Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.619 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -145.37 93.31 2.35 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t 64.82 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 126.332 1.853 . . . . 0.0 108.956 -165.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -81.17 143.96 31.99 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.363 0.983 . . . . 0.0 110.462 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.586 2.136 . . . . 0.0 108.653 171.774 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.6 92.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.05 1.74 . . . . 0.0 110.329 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.77 18.54 11.2 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.316 1.846 . . . . 0.0 115.88 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p -133.16 176.36 8.57 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 169.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p -103.41 113.86 65.35 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.67 -37.17 70.69 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.837 3.025 . . . . 0.0 117.21 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 40.56 68.63 0.39 Allowed 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.976 2.11 . . . . 0.0 112.939 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.51 -39.89 15.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.047 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.7 mm 67.17 93.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 126.562 1.945 . . . . 0.0 107.926 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.0 ttm 61.98 -94.33 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 126.549 1.939 . . . . 0.0 110.109 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 70.92 134.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.115 2.166 . . . . 0.0 110.075 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.89 96.63 1.43 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.932 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -22.09 61.41 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.6 p -91.54 108.21 19.74 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.891 1.678 . . . . 0.0 108.187 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -99.39 -66.32 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.719 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.121 1.915 . . . . 0.0 109.543 178.701 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.0 -65.44 1.02 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -149.87 75.35 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 126.266 2.936 . . . . 0.0 107.133 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p -160.07 165.27 32.14 Favored 'General case' 0 CA--C 1.567 1.621 1 CA-C-N 107.628 -4.351 . . . . 0.0 109.987 172.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 23' ' ' ARG . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.94 165.95 0.13 Allowed Pre-proline 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.39 168.93 18.18 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.779 3.653 . . . . 0.0 115.272 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -90.71 81.53 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.8 tp -173.1 114.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -98.1 69.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 123.064 1.412 . . . . 0.0 108.206 173.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 ttt -165.69 90.5 0.47 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -139.89 141.7 36.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.913 0.863 . . . . 0.0 109.604 -162.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.72 -77.31 0.84 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.925 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.61 104.44 12.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.2 p -151.85 116.52 5.12 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.498 0.666 . . . . 0.0 109.557 -166.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -153.27 139.5 18.43 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 124.577 2.132 . . . . 0.0 109.07 173.184 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -103.21 108.2 19.32 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 179.04 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p -144.02 170.63 15.56 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 111.607 -2.542 . . . . 0.0 111.123 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -87.14 122.83 70.84 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.63 -59.98 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.037 3.158 . . . . 0.0 115.344 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 49.86 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 128.805 2.842 . . . . 0.0 114.744 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 tt 69.56 104.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 126.382 1.873 . . . . 0.0 109.477 169.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.11 135.05 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 ttt -86.49 108.08 18.37 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.51 131.0 57.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.49 81.31 1.33 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.762 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mp -93.75 -69.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -91.77 -69.08 0.76 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -149.18 106.86 3.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 124.304 2.002 . . . . 0.0 108.371 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 121.658 0.742 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.0 82.58 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.74 19.99 4.78 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.97 169.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 C-N-CA 128.167 2.587 . . . . 0.0 112.854 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -144.03 138.51 15.07 Favored Pre-proline 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.28 161.69 34.7 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.372 2.715 . . . . 0.0 113.549 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.54 107.41 6.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 79.94 114.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -88.46 103.48 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -160.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 tpt -154.65 111.19 3.27 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -95.68 133.71 39.45 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.068 0.937 . . . . 0.0 109.276 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.65 -107.85 1.07 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.178 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.98 -64.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.024 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.2 p -79.93 135.84 36.51 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.463 0.705 . . . . 0.0 110.423 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -76.69 -75.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 117.747 -1.12 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.615 1.197 . . . . 0.0 110.889 179.196 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.81 111.43 5.73 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 58.2 23.28 10.1 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p -142.73 176.93 8.67 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.391 1.077 . . . . 0.0 110.998 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p -94.13 121.52 63.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -48.84 -54.42 5.43 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.916 3.078 . . . . 0.0 115.055 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -152.32 -76.5 0.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.84 132.2 54.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pp -91.23 98.01 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.12 127.27 10.5 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -98.37 131.27 44.8 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.43 80.85 1.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.405 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.7 tp 61.26 -97.47 0.07 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.277 1.831 . . . . 0.0 110.038 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 134.79 14.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.338 1.426 . . . . 0.0 109.243 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -138.35 113.46 9.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.618 1.199 . . . . 0.0 110.535 -179.213 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -112.03 96.12 5.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.373 -1.344 . . . . 0.0 107.373 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 t30 175.78 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p -125.49 171.16 10.73 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 108.636 -3.893 . . . . 0.0 110.772 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.424 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -142.09 132.2 12.58 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.42 85.93 1.22 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.643 2.895 . . . . 0.0 112.331 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 63.02 113.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 126.385 1.874 . . . . 0.0 109.208 -169.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -78.11 128.23 33.5 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.5 pt -84.99 131.44 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.129 0.966 . . . . 0.0 108.801 -170.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.33 116.52 25.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -123.72 136.59 54.54 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.035 0.921 . . . . 0.0 109.116 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.477 1.414 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.27 90.24 5.78 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 167.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -131.43 68.98 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.918 0.866 . . . . 0.0 108.86 173.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.03 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.768 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.198 1.951 . . . . 0.0 108.606 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.94 -57.97 0.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.577 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -137.73 9.18 2.85 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -147.05 169.51 19.1 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.393 1.077 . . . . 0.0 110.876 172.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' HB ' ' A' ' 17' ' ' THR . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 5' ' ' ILE . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.655 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.4 140.77 17.06 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.5 73.15 5.26 Favored 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 123.396 2.731 . . . . 0.0 113.599 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 mtp-105 47.21 70.75 0.38 Allowed 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 125.923 1.689 . . . . 0.0 111.764 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.9 tp -157.38 108.62 2.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -88.57 124.27 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.4 ptm -102.95 100.17 10.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -152.27 136.83 16.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.88 99.69 2.56 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-N 114.57 -1.195 . . . . 0.0 112.523 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.37 127.92 10.76 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -94.33 -69.79 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.677 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -95.34 -67.07 0.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.57 0.748 . . . . 0.0 109.884 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 124.612 2.149 . . . . 0.0 110.331 -173.07 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.562 1.418 0 CA-C-O 122.178 0.989 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -140.22 -91.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 174.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -95.27 2.62 54.87 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 169.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p -159.06 165.86 32.96 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 125.843 1.657 . . . . 0.0 108.775 169.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p -103.77 121.61 47.51 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -52.84 157.38 7.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 124.607 3.538 . . . . 0.0 116.575 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -140.53 126.98 20.04 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 43.02 -157.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 127.467 2.307 . . . . 0.0 114.029 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm 74.04 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 C-N-CA 126.869 2.068 . . . . 0.0 107.546 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 ptm -114.2 165.71 12.39 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.408 1.099 . . . . 0.0 110.063 164.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.02 141.38 43.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.793 0.806 . . . . 0.0 110.831 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.32 -103.67 3.05 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.036 -175.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.1 mt -94.38 118.71 32.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.8 m -80.11 118.87 22.2 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.181 0.515 . . . . 0.0 110.608 -170.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -135.1 -75.66 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 124.118 1.914 . . . . 0.0 108.288 -178.112 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 CA--C 1.558 1.279 0 CA-C-O 118.345 -0.836 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.47 90.28 0.06 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.271 1.829 . . . . 0.0 109.555 -173.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -102.28 -77.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.763 0.792 . . . . 0.0 109.331 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p -125.09 174.13 8.25 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.972 172.01 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -144.44 136.52 13.13 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.06 88.49 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 123.963 3.109 . . . . 0.0 113.061 -176.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -90.35 123.24 33.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.768 -169.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.2 mt -72.92 -56.5 5.08 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.076 174.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.81 111.03 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 163.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.6 ttt -64.16 -41.23 97.23 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.22 134.15 44.22 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.047 0.84 . . . . 0.0 110.766 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.23 -153.38 14.37 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 122.128 0.849 . . . . 0.0 112.616 178.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.7 tp -147.81 -70.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -103.12 91.35 4.07 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -139.91 125.53 19.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 122.42 1.105 . . . . 0.0 110.601 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -133.41 121.66 22.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 171.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -100.19 17.26 21.72 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p -141.56 169.41 17.66 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 124.825 1.25 . . . . 0.0 110.487 172.339 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.641 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -128.15 129.03 23.69 Favored Pre-proline 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.56 102.42 1.4 Allowed 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.138 2.559 . . . . 0.0 112.454 -171.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -101.04 88.35 3.5 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 83.25 2.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 169.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.4 pt 34.84 69.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 C-N-CA 126.977 2.111 . . . . 0.0 111.825 -158.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 52.0 mtt -127.9 89.05 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -167.86 149.29 5.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.865 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.55 -77.88 0.59 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.965 169.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -143.18 116.05 8.79 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m 67.84 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.497 1.919 . . . . 0.0 110.243 174.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -152.42 129.53 11.13 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.133 1.921 . . . . 0.0 108.951 170.07 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.95 87.33 0.09 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 126.078 1.751 . . . . 0.0 110.072 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 179.17 92.95 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 171.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p -111.33 176.24 5.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 111.788 -2.46 . . . . 0.0 111.66 -171.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -145.26 142.96 18.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.66 157.96 57.13 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.859 3.04 . . . . 0.0 114.009 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 73.33 127.28 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 126.306 1.842 . . . . 0.0 108.496 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.27 176.89 2.53 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 123.587 0.755 . . . . 0.0 112.405 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.2 pt -66.29 121.04 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.025 0.917 . . . . 0.0 110.094 -171.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 30.2 ttp -94.87 124.4 38.89 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -75.14 128.78 36.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.192 0.996 . . . . 0.0 108.657 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -85.44 0.39 Allowed Glycine 0 CA--C 1.54 1.614 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.12 -159.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.5 mt -125.78 102.18 7.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.8 m -86.63 126.3 34.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.878 0.471 . . . . 0.0 109.807 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 p90 43.7 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 127.014 2.126 . . . . 0.0 112.087 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 124.578 2.132 . . . . 0.0 110.612 -176.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.525 0.679 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.412 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.411 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p . . . . . 0 CA--C 1.567 1.618 0 CA-C-O 121.321 0.581 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p . . . . . 0 CA--C 1.567 1.616 0 CA-C-O 121.604 0.716 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.527 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p . . . . . 0 CA--C 1.567 1.602 0 CA-C-O 121.817 0.818 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p . . . . . 0 CA--C 1.571 1.777 0 CA-C-O 122.156 0.979 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.582 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.472 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 121.048 0.451 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB ' ' A' ' 17' ' ' THR . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB3' HG13 ' A' ' 5' ' ' ILE . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p . . . . . 0 CA--C 1.571 1.765 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.954 0.883 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p . . . . . 0 CA--C 1.569 1.694 0 CA-C-O 121.558 0.694 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.561 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.531 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 17' ' ' THR . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.593 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p . . . . . 0 CA--C 1.568 1.667 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG21 ' SG ' ' A' ' 36' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.655 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p . . . . . 0 CA--C 1.567 1.621 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 23' ' ' ARG . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p . . . . . 0 CA--C 1.579 2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 121.603 0.716 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p . . . . . 0 CA--C 1.57 1.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.424 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' HB ' ' A' ' 17' ' ' THR . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 5' ' ' ILE . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.655 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 121.783 0.801 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 122.127 0.965 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.641 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p . . . . . 0 CA--C 1.569 1.681 0 CA-C-O 121.348 0.594 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 CA--C 1.554 1.125 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.04 115.28 21.6 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -173.9 87.94 0.06 Allowed 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 124.885 2.279 . . . . 0.0 105.38 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.3 p -139.26 170.87 15.17 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 110.989 -2.823 . . . . 0.0 110.49 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 62.8 mt -108.33 98.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.8 17.32 0.73 Allowed 'General case' 0 CA--C 1.583 2.25 0 O-C-N 119.322 -2.111 . . . . 0.0 114.535 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 43.9 mt-10 -113.33 159.46 19.38 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.526 1.53 . . . . 0.0 113.141 -170.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -107.65 5.82 27.21 Favored 'General case' 0 N--CA 1.514 2.732 0 N-CA-C 119.989 3.329 . . . . 0.0 119.989 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -149.67 34.02 0.69 Allowed 'General case' 0 CA--C 1.581 2.14 0 CA-C-N 109.143 -3.662 . . . . 0.0 109.649 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.69 175.4 34.13 Favored Glycine 0 N--CA 1.487 2.086 0 O-C-N 120.917 -1.114 . . . . 0.0 114.109 169.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -94.51 127.64 40.57 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -140.17 -175.49 4.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 123.085 1.421 . . . . 0.0 110.676 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 m -140.64 162.49 35.27 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.524 2.106 . . . . 0.0 109.08 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -94.63 93.32 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 111.648 -2.524 . . . . 0.0 106.497 168.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.17 -41.58 2.01 Favored Glycine 0 CA--C 1.551 2.29 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.791 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.17 -151.37 0.31 Allowed Glycine 0 CA--C 1.542 1.733 0 CA-C-O 122.381 0.989 . . . . 0.0 114.417 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -71.09 141.14 50.84 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 123.282 1.515 . . . . 0.0 107.988 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -106.1 177.28 4.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.365 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.536 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.5 m -82.62 142.02 32.07 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 126.367 2.984 . . . . 0.0 108.756 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.4 -50.15 12.58 Favored 'General case' 0 CA--C 1.559 1.296 1 CA-C-N 106.886 -4.688 . . . . 0.0 116.905 -163.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.71 39.68 1.02 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.772 1.273 . . . . 0.0 113.362 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.66 48.84 84.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.412 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 23.8 mmt180 -105.87 134.6 19.66 Favored Pre-proline 0 CA--C 1.57 1.735 0 CA-C-N 113.783 -1.208 . . . . 0.0 108.743 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.72 174.77 12.11 Favored 'Trans proline' 0 CA--C 1.559 1.759 0 C-N-CA 123.073 2.515 . . . . 0.0 114.425 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -135.27 143.3 46.19 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 123.32 1.533 . . . . 0.0 108.955 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -137.44 135.04 36.51 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 7.1 m -74.48 167.32 21.95 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.255 1.979 . . . . 0.0 114.215 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 m -51.31 179.47 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 111.254 -2.703 . . . . 0.0 114.582 169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.29 -33.64 76.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.53 -39.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-O 117.814 -1.088 . . . . 0.0 112.04 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -45.71 1.12 Allowed Glycine 0 N--CA 1.488 2.16 0 CA-C-N 120.063 1.301 . . . . 0.0 115.067 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.0 p -98.21 167.9 10.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.918 0.887 . . . . 0.0 109.249 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 69.52 71.82 0.25 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.853 1.661 . . . . 0.0 107.497 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.9 m -71.4 165.95 22.7 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 25.7 mt-10 -123.49 170.39 10.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 123.219 1.485 . . . . 0.0 108.686 168.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -90.19 157.91 17.49 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.359 1.552 . . . . 0.0 108.496 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.6 p -140.85 138.27 18.06 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.355 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.68 -52.87 0.87 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 123.185 2.59 . . . . 0.0 114.753 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -155.37 128.79 8.38 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.25 122.48 47.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 tt -76.03 132.55 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.2 tpp 65.13 96.7 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 126.242 1.817 . . . . 0.0 108.595 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.23 129.53 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.938 2.095 . . . . 0.0 109.104 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.63 -109.42 2.49 Favored Glycine 0 N--CA 1.479 1.554 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.1 mt 67.31 151.61 0.07 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.359 1.863 . . . . 0.0 111.709 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.7 p -70.98 126.52 29.8 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.279 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 t80 59.96 91.73 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.248 1.819 . . . . 0.0 109.94 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 122.627 1.203 . . . . 0.0 108.631 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 CA--C 1.559 1.32 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.46 136.99 32.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.508 0.723 . . . . 0.0 109.96 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 61.37 23.27 13.54 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 125.954 1.702 . . . . 0.0 115.581 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 p -96.23 173.76 7.23 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.65 1.18 . . . . 0.0 112.092 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 18.8 mt -106.97 89.93 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 19.13 0.56 Allowed 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.327 -1.483 . . . . 0.0 114.348 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -112.14 168.02 9.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.451 1.596 . . . . 0.0 113.465 -169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -113.53 127.44 56.09 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 100.893 -3.743 . . . . 0.0 100.893 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 61.09 33.44 19.51 Favored 'General case' 0 CA--C 1.592 2.564 0 CA-C-N 111.51 -2.586 . . . . 0.0 112.781 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.74 151.91 23.55 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 167.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -75.79 124.62 27.59 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.931 1.348 . . . . 0.0 109.304 -169.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.8 p -132.42 176.52 8.35 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.47 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.23 153.22 41.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 123.191 1.472 . . . . 0.0 107.058 169.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -83.79 99.35 10.24 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.1 61.81 0.82 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -167.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.44 -152.19 8.92 Favored Glycine 0 N--CA 1.479 1.566 0 CA-C-O 122.805 1.225 . . . . 0.0 110.05 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.99 138.38 33.78 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -99.23 176.9 5.38 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 112.112 -2.313 . . . . 0.0 106.355 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 29.8 m -94.44 108.45 20.38 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 125.015 2.34 . . . . 0.0 105.565 -168.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.4 t 1.01 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.031 2 C-N-CA 132.716 4.407 . . . . 0.0 115.211 -166.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -94.77 29.85 2.23 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 121.471 1.941 . . . . 0.0 115.636 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.78 7.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.411 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -100.62 126.79 34.44 Favored Pre-proline 0 CA--C 1.584 2.271 0 CA-C-N 118.906 1.353 . . . . 0.0 108.803 -175.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.86 -175.73 2.79 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.958 2.439 . . . . 0.0 112.276 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -132.44 145.23 51.04 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.259 1.504 . . . . 0.0 109.37 176.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.66 128.69 41.46 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 66.8 m -77.44 167.79 21.08 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 123.124 1.44 . . . . 0.0 112.987 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 m -60.26 178.66 0.18 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 113.84 -1.527 . . . . 0.0 113.889 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -63.69 -32.07 73.44 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.48 -58.54 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.77 -55.52 0.56 Allowed Glycine 0 N--CA 1.483 1.828 0 C-N-CA 123.254 0.454 . . . . 0.0 112.653 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.4 p -82.33 159.16 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.874 0.845 . . . . 0.0 109.078 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 65.57 69.02 0.47 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 125.611 1.564 . . . . 0.0 108.33 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 80.4 m -71.01 166.42 21.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 122.042 -0.411 . . . . 0.0 111.627 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.3 mt-10 -132.72 170.65 14.94 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.187 1.47 . . . . 0.0 110.843 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.9 m -84.89 162.43 19.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.148 1.379 . . . . 0.0 109.335 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.4 p -141.18 146.6 43.69 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.585 -0.697 . . . . 0.0 109.433 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -63.9 164.85 20.46 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 123.57 2.847 . . . . 0.0 114.434 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.39 125.12 28.63 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.007 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.94 114.31 21.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.9 mm -93.9 106.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -124.82 90.48 3.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.424 1.107 . . . . 0.0 108.926 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.66 63.37 1.77 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 114.343 -1.299 . . . . 0.0 115.392 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -154.58 -73.25 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.3 t -108.01 86.73 2.35 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 162.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -154.91 130.32 9.76 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 122.69 1.233 . . . . 0.0 110.292 169.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.71 -73.25 0.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -90.9 -73.74 0.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.869 0.842 . . . . 0.0 109.53 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.0 p -119.18 170.43 9.09 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.299 169.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 44.9 mt -107.42 95.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.93 15.04 1.95 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 119.37 -2.082 . . . . 0.0 114.235 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.06 149.71 50.14 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -169.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -72.27 136.81 46.4 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 125.155 2.407 . . . . 0.0 104.881 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 52.17 25.78 3.51 Favored 'General case' 0 CA--C 1.587 2.378 0 CA-C-N 109.587 -3.461 . . . . 0.0 113.445 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.42 143.94 27.62 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -76.84 129.56 36.4 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 125.184 2.421 . . . . 0.0 108.955 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 24.1 p -132.67 176.52 8.38 Favored 'General case' 0 N--CA 1.48 1.043 1 CA-C-N 107.871 -4.24 . . . . 0.0 110.375 -175.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.54 152.68 41.74 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -83.7 98.73 9.82 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.38 61.85 0.77 Allowed Glycine 0 CA--C 1.556 2.618 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -167.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.55 -154.08 10.99 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 122.814 1.23 . . . . 0.0 110.093 -168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -83.36 142.16 31.24 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -118.98 179.64 4.09 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.75 2.214 . . . . 0.0 105.413 168.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 2.2 m -77.3 141.18 40.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 126.425 3.012 . . . . 0.0 109.992 -169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.2 t -46.6 -51.48 15.61 Favored 'General case' 0 CA--C 1.554 1.108 1 CA-C-N 106.509 -4.859 . . . . 0.0 116.475 -164.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -91.64 36.21 0.95 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.69 1.233 . . . . 0.0 113.988 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 59.67 5.54 Favored Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.423 -1.262 . . . . 0.0 115.383 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -122.48 121.88 27.51 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-N 114.03 -1.085 . . . . 0.0 109.007 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.24 177.96 0.34 Allowed 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 123.911 3.074 . . . . 0.0 115.744 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -126.99 150.11 49.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 123.146 1.451 . . . . 0.0 109.531 178.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -126.29 122.87 36.72 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.7 m -76.17 168.37 20.17 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 123.005 1.383 . . . . 0.0 112.958 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -60.26 179.7 0.14 Allowed 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 123.123 1.44 . . . . 0.0 113.756 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.89 -33.42 75.97 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.93 1.292 . . . . 0.0 114.376 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -74.7 -58.54 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.9 -56.1 0.53 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.125 0.42 . . . . 0.0 112.747 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.6 p -80.94 159.39 24.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.945 0.878 . . . . 0.0 109.588 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 65.16 66.85 0.53 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.711 1.604 . . . . 0.0 108.604 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.5 m -70.34 165.99 21.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.883 -0.51 . . . . 0.0 111.637 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 mt-10 -133.23 170.62 15.17 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.675 1.226 . . . . 0.0 110.471 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.44 160.7 15.9 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.879 1.323 . . . . 0.0 112.462 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -102.93 146.15 31.87 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.805 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.35 144.75 51.76 Favored 'Trans proline' 0 CA--C 1.558 1.717 0 C-N-CA 124.312 3.341 . . . . 0.0 114.264 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -78.59 129.61 34.98 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.922 0.868 . . . . 0.0 109.951 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.17 154.58 46.99 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.981 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -82.62 128.86 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-O 121.918 0.866 . . . . 0.0 108.87 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.4 ttt -96.58 137.43 35.67 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.933 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.61 131.0 38.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.575 1.179 . . . . 0.0 110.039 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.34 103.71 0.25 Allowed Glycine 0 N--CA 1.478 1.455 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt 81.24 128.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 126.258 1.823 . . . . 0.0 106.104 -151.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.9 p -70.36 117.4 11.86 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.349 0.595 . . . . 0.0 111.056 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.37 -65.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.181 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.658 1.218 . . . . 0.0 110.292 175.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.668 0.747 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.8 119.32 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.697 1.999 . . . . 0.0 109.777 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.1 22.84 12.08 Favored 'General case' 0 N--CA 1.517 2.92 0 C-N-CA 126.373 1.869 . . . . 0.0 115.79 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.1 p -148.02 172.82 13.63 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.764 1.225 . . . . 0.0 110.731 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.6 mt -107.49 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.73 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.3 21.75 0.46 Allowed 'General case' 0 CA--C 1.585 2.324 0 O-C-N 119.432 -2.042 . . . . 0.0 113.756 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -115.57 162.07 17.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 123.953 1.835 . . . . 0.0 114.95 -169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.98 121.49 45.14 Favored 'General case' 0 CA--C 1.552 1.053 1 N-CA-C 100.162 -4.014 . . . . 0.0 100.162 168.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 61.66 41.45 12.1 Favored 'General case' 0 CA--C 1.586 2.334 0 CA-C-N 111.088 -2.778 . . . . 0.0 111.887 -168.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -93.03 145.26 17.51 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -72.44 120.95 18.77 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 123.911 1.815 . . . . 0.0 109.882 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.0 p -130.23 177.68 7.14 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 110.666 -2.97 . . . . 0.0 110.339 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.76 153.44 44.58 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -84.03 97.62 9.39 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.26 63.81 0.8 Allowed Glycine 0 CA--C 1.554 2.52 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.1 9.27 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -82.36 138.51 34.47 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -108.99 178.05 4.58 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.514 -2.584 . . . . 0.0 105.953 168.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -79.05 143.16 35.88 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 126.387 2.994 . . . . 0.0 109.839 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.07 -47.23 45.17 Favored 'General case' 0 CA--C 1.556 1.182 1 CA-C-N 106.729 -4.759 . . . . 0.0 116.385 -164.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -89.0 31.95 0.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.02 57.42 17.32 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 124.827 1.203 . . . . 0.0 115.543 -170.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -118.13 134.12 23.38 Favored Pre-proline 0 CA--C 1.567 1.62 0 CA-C-N 114.207 -0.996 . . . . 0.0 109.536 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.82 175.0 11.47 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 123.214 2.61 . . . . 0.0 113.924 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -120.1 147.85 44.34 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.422 1.582 . . . . 0.0 109.582 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.57 120.78 35.83 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 61.4 m -77.48 168.78 19.44 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.977 1.37 . . . . 0.0 112.137 -168.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -70.95 -166.65 0.16 Allowed 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 123.726 1.727 . . . . 0.0 112.887 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -66.88 -44.24 81.4 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.389 -1.732 . . . . 0.0 114.446 -170.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -74.46 -39.74 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.43 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.79 -44.58 1.23 Allowed Glycine 0 N--CA 1.485 1.966 0 CA-C-N 119.65 1.114 . . . . 0.0 114.689 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -89.79 157.82 17.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.382 1.087 . . . . 0.0 109.337 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.1 m120 65.13 72.11 0.44 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.869 1.668 . . . . 0.0 108.069 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 64.4 m -69.65 169.01 13.62 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.034 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.23 160.87 39.38 Favored 'General case' 0 N--CA 1.508 2.43 0 CA-C-O 123.033 1.397 . . . . 0.0 110.186 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.527 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 1.6 m -72.33 161.14 31.24 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.554 1.142 . . . . 0.0 111.163 -169.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 t -136.77 138.89 27.43 Favored Pre-proline 0 CA--C 1.573 1.843 0 O-C-N 121.444 -0.785 . . . . 0.0 109.295 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.63 124.39 8.78 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.952 3.101 . . . . 0.0 112.686 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -120.2 -90.86 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.33 102.67 4.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -76.01 132.08 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.244 1.021 . . . . 0.0 109.182 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.8 mtp -90.22 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.864 -172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 72.12 127.44 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.014 2.126 . . . . 0.0 109.136 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.52 -83.4 0.08 OUTLIER Glycine 0 N--CA 1.481 1.665 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.059 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.23 89.56 3.11 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 160.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.7 t -143.94 -74.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 63.64 92.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 126.474 1.91 . . . . 0.0 110.333 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 122.59 1.186 . . . . 0.0 108.796 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.81 -63.42 1.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.801 0.841 . . . . 0.0 109.472 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 m120 59.51 21.32 9.81 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 126.394 1.878 . . . . 0.0 115.742 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.8 p -147.64 169.38 19.77 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 125.044 1.338 . . . . 0.0 110.503 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 mt -109.99 96.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.96 19.37 0.42 Allowed 'General case' 0 CA--C 1.585 2.31 0 O-C-N 119.463 -2.023 . . . . 0.0 114.018 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -115.63 159.19 21.64 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 123.816 1.769 . . . . 0.0 114.936 -169.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -109.32 122.69 47.9 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 100.37 -3.937 . . . . 0.0 100.37 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 61.07 37.56 17.77 Favored 'General case' 0 CA--C 1.59 2.497 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.895 -168.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.21 147.47 20.86 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -75.9 124.68 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.988 1.851 . . . . 0.0 108.164 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.5 p -135.19 -175.73 4.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 110.561 -3.018 . . . . 0.0 110.147 -169.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 149.4 36.65 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.288 1.518 . . . . 0.0 108.977 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -90.47 99.38 12.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.26 72.68 1.24 Allowed Glycine 0 CA--C 1.555 2.55 0 N-CA-C 103.136 -3.986 . . . . 0.0 103.136 -165.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.94 -154.33 11.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 122.497 1.054 . . . . 0.0 113.23 -166.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -90.48 141.09 29.11 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 167.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -112.0 179.5 3.99 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 124.879 2.276 . . . . 0.0 105.998 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.1 m -81.65 141.23 33.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 126.267 2.937 . . . . 0.0 109.659 -169.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -48.7 -53.69 17.82 Favored 'General case' 0 CA--C 1.557 1.234 1 CA-C-N 106.863 -4.699 . . . . 0.0 116.129 -164.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -92.17 36.39 0.98 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.891 1.329 . . . . 0.0 114.067 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.43 61.4 3.65 Favored Glycine 0 N--CA 1.481 1.649 0 CA-C-N 114.507 -1.224 . . . . 0.0 115.206 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.25 131.5 23.97 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 113.662 -1.269 . . . . 0.0 108.769 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.02 -179.65 5.64 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.163 2.575 . . . . 0.0 113.83 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -130.47 146.98 52.11 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.971 1.367 . . . . 0.0 109.381 177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.6 mmt-85 -132.49 130.68 40.77 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.9 m -75.34 165.67 24.8 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 123.098 1.428 . . . . 0.0 113.28 -168.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -70.85 -166.77 0.16 Allowed 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 123.684 1.707 . . . . 0.0 113.003 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -64.39 -34.9 79.25 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.496 -1.684 . . . . 0.0 114.287 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.78 -58.96 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.01 -55.39 0.68 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -87.54 155.68 19.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.218 1.008 . . . . 0.0 108.535 169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 66.64 74.58 0.34 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.744 1.618 . . . . 0.0 107.342 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 82.6 m -69.55 169.92 11.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.866 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 5.8 mt-10 -134.73 169.69 16.96 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.892 1.329 . . . . 0.0 111.096 171.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -89.4 159.37 17.35 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.589 1.185 . . . . 0.0 109.563 -169.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.6 p -137.03 131.03 17.72 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -171.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.73 -78.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 123.215 2.61 . . . . 0.0 112.596 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -139.15 -52.98 0.56 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.136 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp 73.63 -79.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 127.592 2.357 . . . . 0.0 108.248 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.8 mm 68.29 93.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 126.581 1.952 . . . . 0.0 106.423 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.71 153.3 51.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.793 0.806 . . . . 0.0 110.02 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 71.95 137.53 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 126.808 2.043 . . . . 0.0 109.539 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.2 -74.58 0.61 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.273 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.66 104.3 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 p -127.23 96.2 4.51 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -98.6 -67.11 0.86 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.102 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 124.553 2.121 . . . . 0.0 110.24 -173.695 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 CA--C 1.559 1.295 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -96.34 126.01 41.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.841 0.746 . . . . 0.0 109.04 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -73.48 -33.14 64.69 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 14.4 p 67.86 162.11 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 129.058 2.943 . . . . 0.0 110.957 -169.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.582 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 12.4 mm -106.89 98.66 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.888 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.29 11.27 1.99 Allowed 'General case' 0 CA--C 1.579 2.064 0 O-C-N 120.029 -1.669 . . . . 0.0 114.426 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -135.86 144.65 45.73 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -77.11 130.79 37.83 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 57.04 31.24 19.58 Favored 'General case' 0 CA--C 1.588 2.41 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.59 -168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.78 151.08 27.28 Favored Glycine 0 C--N 1.36 1.912 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 167.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -77.21 128.11 33.81 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 125.096 2.379 . . . . 0.0 106.732 -169.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 11.7 p -142.83 -171.12 3.38 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 108.403 -3.999 . . . . 0.0 110.54 -168.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.472 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -145.02 139.4 27.42 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.982 171.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -91.37 109.73 21.02 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.81 72.28 1.28 Allowed Glycine 0 CA--C 1.558 2.741 1 N-CA-C 100.358 -5.097 . . . . 0.0 100.358 -164.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 171.96 -143.27 7.38 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 122.768 1.204 . . . . 0.0 111.529 -164.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -90.9 135.27 33.84 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -115.68 177.11 4.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 124.87 2.272 . . . . 0.0 105.285 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.7 m -71.12 144.19 50.35 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 126.479 3.038 . . . . 0.0 110.523 -169.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.3 t -52.28 -48.96 65.03 Favored 'General case' 0 CA--C 1.557 1.22 1 CA-C-N 106.621 -4.809 . . . . 0.0 116.234 -164.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -91.0 36.19 0.91 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.787 1.279 . . . . 0.0 113.819 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.81 60.74 5.48 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.578 1.085 . . . . 0.0 114.862 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.3 mmt-85 -131.19 145.33 57.27 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-N 113.136 -1.532 . . . . 0.0 109.983 -168.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.17 168.43 24.73 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.75 2.3 . . . . 0.0 114.912 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.09 130.79 25.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -142.78 136.81 29.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.8 m -74.29 -175.77 2.41 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 124.302 2.001 . . . . 0.0 113.728 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -74.77 -163.76 0.24 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 112.022 -2.353 . . . . 0.0 111.209 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -50.26 52.55 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.927 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.97 -29.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 CA-C-O 118.299 -0.858 . . . . 0.0 112.716 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.68 -22.77 18.86 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 116.801 1.48 . . . . 0.0 116.801 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -82.46 160.66 22.63 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 56.93 58.41 4.05 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 125.713 1.605 . . . . 0.0 110.644 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.2 m -66.38 151.46 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 110.813 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 12.9 mt-10 -132.4 175.78 8.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.531 1.158 . . . . 0.0 111.109 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.44 156.23 19.24 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.05 1.405 . . . . 0.0 108.238 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.8 p -128.35 132.42 24.34 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -41.77 -65.01 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 124.878 3.718 . . . . 0.0 116.429 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -155.3 -78.05 0.09 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.683 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp 68.39 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 126.515 1.926 . . . . 0.0 107.109 -169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -121.4 131.51 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 158.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 ttp -79.92 122.63 26.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.724 -0.61 . . . . 0.0 109.989 -172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.06 112.27 12.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.71 -85.87 0.08 OUTLIER Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp 57.75 85.69 0.08 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.322 1.849 . . . . 0.0 110.799 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 p -160.82 104.24 1.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.9 t80 62.59 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.781 1.633 . . . . 0.0 108.912 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 124.6 2.143 . . . . 0.0 111.952 177.737 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.04 95.69 7.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 177.94 91.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.9 p -140.1 171.19 14.53 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 111.441 -2.618 . . . . 0.0 110.765 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB ' ' A' ' 17' ' ' THR . 9.3 mm -105.43 91.23 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.42 21.63 0.61 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -118.55 163.81 16.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.563 1.545 . . . . 0.0 113.218 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -108.69 122.78 47.83 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 100.866 -3.753 . . . . 0.0 100.866 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 58.63 41.04 22.82 Favored 'General case' 0 CA--C 1.588 2.436 0 CA-C-N 112.091 -2.322 . . . . 0.0 111.255 -168.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.29 147.67 19.69 Favored Glycine 0 C--N 1.364 2.09 0 CA-C-O 122.075 0.82 . . . . 0.0 112.426 169.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.55 123.44 23.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 123.693 1.711 . . . . 0.0 108.956 -169.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB3' HG13 ' A' ' 5' ' ' ILE . 17.6 p -143.56 -176.89 5.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 111.368 -2.651 . . . . 0.0 109.778 -169.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.12 154.44 41.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.796 1.76 . . . . 0.0 109.26 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -84.37 111.17 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.305 -2.225 . . . . 0.0 105.758 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 67.25 1.49 Allowed Glycine 0 CA--C 1.55 2.226 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -167.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.26 -149.56 9.54 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-O 123.382 1.545 . . . . 0.0 109.711 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -78.76 134.31 37.05 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.833 -1.684 . . . . 0.0 107.956 172.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -108.54 175.75 5.36 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 125.047 2.356 . . . . 0.0 105.457 168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 86.6 m -76.72 143.3 40.07 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 124.485 2.088 . . . . 0.0 109.282 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -54.19 -47.79 71.67 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 110.674 -2.966 . . . . 0.0 117.399 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -90.7 37.09 0.91 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 123.218 1.485 . . . . 0.0 113.599 -172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.58 59.75 9.31 Favored Glycine 0 N--CA 1.487 2.038 0 CA-C-N 114.163 -1.38 . . . . 0.0 114.196 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 20.7 mmt85 -124.22 145.33 48.19 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.192 -1.504 . . . . 0.0 110.379 -168.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.5 162.51 30.48 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 123.206 2.604 . . . . 0.0 113.932 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -124.0 144.92 49.54 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -143.63 143.37 31.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 10.2 m -74.79 166.39 23.69 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-O 124.549 2.119 . . . . 0.0 114.357 -168.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -59.38 -164.42 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 110.669 -2.969 . . . . 0.0 113.778 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.73 -37.9 79.8 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.78 -1.555 . . . . 0.0 114.086 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.87 -43.11 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.669 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.45 -46.23 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-N 120.106 1.321 . . . . 0.0 115.227 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -101.85 165.8 11.0 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.766 0.826 . . . . 0.0 109.313 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 m120 68.92 74.74 0.25 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.809 1.644 . . . . 0.0 107.089 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 49.6 m -73.45 167.34 21.48 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.9 177.53 7.19 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.877 0.846 . . . . 0.0 110.047 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t -82.72 139.18 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -0.999 . . . . 0.0 108.763 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 p -110.93 123.28 35.8 Favored Pre-proline 0 CA--C 1.57 1.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -84.04 147.97 11.88 Favored 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.271 2.648 . . . . 0.0 114.263 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -84.23 -62.45 1.56 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.1 tp -106.81 -89.63 0.44 Allowed 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.19 132.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 tpt -138.75 81.94 1.87 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 60.48 120.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 126.949 2.099 . . . . 0.0 112.07 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.77 81.11 0.17 Allowed Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.869 -1.514 . . . . 0.0 115.508 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.3 tp -94.33 105.09 17.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.2 p -109.29 79.87 1.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.967 0.889 . . . . 0.0 108.863 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -89.04 -65.29 1.03 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.808 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 122.618 1.199 . . . . 0.0 110.353 -178.801 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -108.61 116.72 32.5 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 m120 60.06 80.16 0.21 Allowed 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 125.157 2.408 . . . . 0.0 108.664 -173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 15.8 p -53.78 167.45 0.25 Allowed 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 109.25 -3.613 . . . . 0.0 115.953 -168.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.71 94.05 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.94 19.54 1.11 Allowed 'General case' 0 CA--C 1.586 2.338 0 O-C-N 120.275 -1.516 . . . . 0.0 113.924 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 48.2 mt-10 -109.93 169.28 8.82 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 123.122 1.439 . . . . 0.0 114.804 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -114.83 120.6 40.56 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 100.451 -3.907 . . . . 0.0 100.451 167.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 52.59 51.23 16.51 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-N 110.337 -3.12 . . . . 0.0 111.631 -167.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.04 -165.09 7.43 Favored Glycine 0 N--CA 1.489 2.192 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.398 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -95.85 136.09 36.73 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.7 p -146.7 176.14 10.08 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.865 1.317 . . . . 0.0 111.575 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.34 150.87 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 168.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -83.4 101.64 11.49 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.3 65.96 0.98 Allowed Glycine 0 CA--C 1.553 2.421 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.56 -147.27 6.67 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-O 123.009 1.338 . . . . 0.0 109.96 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.84 138.95 36.22 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.27 176.64 4.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 111.13 -2.759 . . . . 0.0 105.881 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 88.7 m -81.93 139.56 34.55 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.657 2.17 . . . . 0.0 108.431 -168.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -49.4 -54.21 18.66 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 109.956 -3.293 . . . . 0.0 117.047 -163.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -91.86 35.97 0.97 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.49 64.67 2.66 Favored Glycine 0 N--CA 1.482 1.749 0 CA-C-N 114.005 -1.452 . . . . 0.0 113.838 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 3.7 mmp_? -133.26 147.14 63.86 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 113.433 -1.384 . . . . 0.0 110.773 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.34 176.09 9.58 Favored 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 123.232 2.621 . . . . 0.0 114.275 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 130.05 42.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -119.46 123.08 43.19 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 79.9 m -74.6 171.63 13.5 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.733 1.254 . . . . 0.0 112.639 -168.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -64.09 -170.55 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 123.649 1.69 . . . . 0.0 113.154 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 76.0 mtp -69.98 -38.57 76.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.694 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.84 -58.03 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.76 -53.76 0.5 Allowed Glycine 0 N--CA 1.483 1.772 0 CA-C-N 118.056 0.389 . . . . 0.0 113.156 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 p -81.23 159.58 24.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.406 1.098 . . . . 0.0 109.962 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 69.51 64.69 0.26 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.075 1.75 . . . . 0.0 108.875 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.3 m -71.11 167.56 19.05 Favored 'General case' 0 CA--C 1.57 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 111.355 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 35.6 mt-10 -130.42 -174.6 3.39 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.343 0.592 . . . . 0.0 111.552 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 7' ' ' GLU . 8.3 t -88.17 177.83 6.79 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-O 123.822 1.772 . . . . 0.0 109.84 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 4.3 p -28.92 165.33 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.499 3.518 . . . . 0.0 120.499 168.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.77 151.4 68.97 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 124.79 3.66 . . . . 0.0 113.491 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -70.59 152.73 43.61 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.389 0.614 . . . . 0.0 111.273 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.06 147.09 40.52 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.892 0.877 . . . . 0.0 112.594 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.5 mm 76.8 130.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -157.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -59.95 132.98 55.63 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.817 0.847 . . . . 0.0 111.917 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 73.9 142.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.592 1.957 . . . . 0.0 108.677 -163.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.27 103.49 0.48 Allowed Glycine 0 CA--C 1.547 2.044 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 tt -142.73 -58.32 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.646 0.778 . . . . 0.0 109.707 -164.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t 69.62 99.62 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 127.01 2.124 . . . . 0.0 109.538 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 65.51 107.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.278 1.831 . . . . 0.0 110.32 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 122.561 1.172 . . . . 0.0 109.943 179.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -105.49 62.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.841 0.829 . . . . 0.0 110.762 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 177.66 91.02 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.0 p -156.14 172.97 17.51 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 112.11 -2.314 . . . . 0.0 111.507 -169.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 39.7 mt -108.91 99.85 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.15 17.84 0.95 Allowed 'General case' 0 CA--C 1.581 2.155 0 O-C-N 119.59 -1.944 . . . . 0.0 114.032 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -137.88 143.68 40.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.09 129.2 37.38 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 57.04 26.18 11.65 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 112.308 -2.224 . . . . 0.0 114.199 -168.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.05 150.05 35.15 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.17 133.76 45.31 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 124.583 2.135 . . . . 0.0 109.53 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 10.1 p -138.36 -178.69 5.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 109.055 -3.702 . . . . 0.0 110.975 -169.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.51 152.53 39.9 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 113.127 -1.851 . . . . 0.0 107.925 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -90.43 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.7 71.21 1.2 Allowed Glycine 0 CA--C 1.556 2.594 0 N-CA-C 103.685 -3.766 . . . . 0.0 103.685 -165.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.02 -151.57 8.13 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.592 1.107 . . . . 0.0 111.89 -166.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -90.42 143.91 26.31 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 167.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.95 177.81 4.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 124.56 2.124 . . . . 0.0 106.037 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.4 m -77.97 142.65 38.18 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 126.635 3.112 . . . . 0.0 109.401 -170.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 t -48.4 -50.73 29.76 Favored 'General case' 0 CA--C 1.558 1.286 1 CA-C-N 106.315 -4.948 . . . . 0.0 116.458 -163.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -91.37 35.39 0.93 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.868 1.318 . . . . 0.0 114.126 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 62.41 4.92 Favored Glycine 0 N--CA 1.484 1.841 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.786 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -126.94 135.18 26.97 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-N 113.19 -1.505 . . . . 0.0 108.374 -169.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.47 173.53 13.67 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 C-N-CA 122.4 2.067 . . . . 0.0 114.541 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 127.05 36.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.83 131.9 53.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 72.3 m -74.8 168.24 20.27 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.973 1.368 . . . . 0.0 113.184 -168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 m -57.82 175.73 0.18 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.587 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 49.7 mtt -64.9 -32.82 74.71 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.54 -59.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.29 -55.13 0.49 Allowed Glycine 0 N--CA 1.483 1.824 0 CA-C-N 118.115 0.416 . . . . 0.0 113.262 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -81.07 159.54 24.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.973 0.892 . . . . 0.0 109.536 170.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.2 68.71 0.49 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 125.71 1.604 . . . . 0.0 108.214 -169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 75.4 m -72.24 162.86 28.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.995 -0.441 . . . . 0.0 110.832 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 16.1 mt-10 -131.88 177.75 7.3 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.8 1.286 . . . . 0.0 110.299 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.47 -178.99 5.72 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 124.909 2.29 . . . . 0.0 108.17 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -35.39 166.18 0.03 OUTLIER Pre-proline 0 CA--C 1.584 2.28 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.7 153.23 78.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 125.223 3.948 . . . . 0.0 113.47 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -58.64 118.1 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.149 0.976 . . . . 0.0 112.477 -169.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.7 tp -146.38 152.01 38.39 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.106 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.21 105.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 122.575 1.179 . . . . 0.0 110.86 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 mtt -154.56 112.27 3.45 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 65.91 159.57 0.12 Allowed 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 125.782 1.633 . . . . 0.0 112.465 168.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.59 81.92 1.34 Allowed Glycine 0 N--CA 1.483 1.808 0 O-C-N 121.345 -0.847 . . . . 0.0 111.124 162.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.41 -80.6 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -106.72 80.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.524 1.057 . . . . 0.0 108.15 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.9 t80 57.5 -95.94 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.345 1.858 . . . . 0.0 109.097 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 120.098 1.317 . . . . 0.0 107.757 170.537 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.63 106.13 10.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -74.21 -41.33 61.55 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -148.33 162.59 39.22 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.595 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 56.3 mt -113.25 88.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.2 18.73 0.49 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -100.59 163.02 12.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.507 1.523 . . . . 0.0 114.168 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.85 120.06 41.01 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 101.175 -3.639 . . . . 0.0 101.175 168.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 57.22 37.54 28.36 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 112.314 -2.221 . . . . 0.0 112.51 -168.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.27 141.57 23.22 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.906 -1.121 . . . . 0.0 112.171 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.28 123.65 24.16 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 124.153 1.93 . . . . 0.0 108.203 -169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.6 p -134.56 -173.81 3.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 110.233 -3.167 . . . . 0.0 109.81 -169.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 148.29 30.02 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.031 1.396 . . . . 0.0 109.815 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -90.5 101.92 14.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 73.44 1.28 Allowed Glycine 0 CA--C 1.552 2.358 0 N-CA-C 103.578 -3.809 . . . . 0.0 103.578 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.74 -154.05 12.3 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 122.44 1.022 . . . . 0.0 112.611 -166.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.36 137.67 32.16 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 167.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -98.6 -178.06 3.87 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 124.559 2.123 . . . . 0.0 106.378 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.5 m -76.92 153.58 34.53 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.182 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -67.96 -172.79 0.31 Allowed 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 121.43 0.633 . . . . 0.0 110.312 -167.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 4.48 55.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 129.86 3.264 . . . . 0.0 117.828 -166.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.59 63.69 3.42 Favored Glycine 0 N--CA 1.476 1.326 0 CA-C-N 108.892 -3.776 . . . . 0.0 116.881 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 14.7 mmt180 -124.53 143.85 44.47 Favored Pre-proline 0 CA--C 1.58 2.104 0 O-C-N 124.503 0.767 . . . . 0.0 109.863 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.37 167.24 15.59 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.45 2.767 . . . . 0.0 114.275 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -125.99 152.62 45.46 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.819 1.295 . . . . 0.0 108.889 171.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -145.14 141.77 29.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 m -74.2 167.44 21.58 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 124.185 1.945 . . . . 0.0 113.943 -168.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -58.36 -167.12 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 111.358 -2.656 . . . . 0.0 113.596 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 tpt -68.25 -39.08 82.35 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.03 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.76 -40.84 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.882 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.71 -44.98 1.15 Allowed Glycine 0 N--CA 1.488 2.139 0 CA-C-N 119.995 1.271 . . . . 0.0 115.311 -174.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -103.69 164.78 11.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.757 0.823 . . . . 0.0 109.315 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 68.89 75.41 0.25 Allowed 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 125.767 1.627 . . . . 0.0 106.9 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.2 m -71.11 168.82 16.34 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.414 0.626 . . . . 0.0 112.524 -169.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.4 mt-10 -132.88 170.92 14.62 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.315 1.055 . . . . 0.0 110.075 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.2 t -82.38 133.8 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.7 p -97.37 120.94 59.91 Favored Pre-proline 0 CA--C 1.572 1.794 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.64 28.24 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.157 2.571 . . . . 0.0 116.535 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 49.69 41.08 21.33 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 125.884 1.674 . . . . 0.0 113.505 -170.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.3 mt -151.32 -66.33 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.12 0.968 . . . . 0.0 108.41 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 pt -135.26 109.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.403 0.681 . . . . 0.0 110.783 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 66.6 134.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.977 2.111 . . . . 0.0 110.62 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.96 110.61 0.23 Allowed Glycine 0 N--CA 1.478 1.455 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.716 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 45' ' ' LEU . 2.7 pt? -118.93 169.11 10.17 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.951 0.882 . . . . 0.0 111.682 -170.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.3 m 70.52 107.86 0.06 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 126.703 2.001 . . . . 0.0 109.614 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -141.3 115.59 9.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.241 1.972 . . . . 0.0 109.614 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.11 -73.29 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.11 80.03 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 126.124 2.868 . . . . 0.0 106.363 169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.9 p -157.83 176.84 12.05 Favored 'General case' 0 CA--C 1.569 1.694 1 CA-C-N 107.541 -4.39 . . . . 0.0 110.193 -169.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 mt -111.04 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.45 18.12 0.45 Allowed 'General case' 0 CA--C 1.585 2.302 0 O-C-N 119.438 -2.039 . . . . 0.0 114.319 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 18.9 mm-40 -110.62 151.14 28.01 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.833 1.653 . . . . 0.0 112.689 -170.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -94.81 -5.71 44.53 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 120.489 3.514 . . . . 0.0 120.489 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -146.81 45.42 1.19 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 110.474 -3.057 . . . . 0.0 108.821 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 174.17 53.54 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 123.856 0.741 . . . . 0.0 113.255 169.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -93.68 129.32 40.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.21 176.55 8.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.827 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 154.93 41.77 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 123.909 1.814 . . . . 0.0 106.859 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -81.68 104.76 12.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.759 -2.019 . . . . 0.0 106.746 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.09 -48.41 0.95 Allowed Glycine 0 CA--C 1.555 2.56 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -167.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -159.04 1.25 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.215 1.388 . . . . 0.0 114.328 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -72.3 146.15 47.37 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 122.852 1.311 . . . . 0.0 108.287 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -115.0 178.21 4.37 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 124.462 2.077 . . . . 0.0 105.882 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.561 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 6.4 m -81.85 141.78 33.12 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 126.495 3.045 . . . . 0.0 109.6 -169.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -45.41 -54.95 6.61 Favored 'General case' 0 CA--C 1.557 1.222 1 CA-C-N 106.471 -4.877 . . . . 0.0 116.415 -164.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -92.28 35.17 1.01 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 63.83 2.79 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.609 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 36.9 ttm180 -123.42 124.23 26.35 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-N 113.262 -1.469 . . . . 0.0 108.319 -169.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 165.08 29.22 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.228 2.619 . . . . 0.0 113.681 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -116.32 147.62 41.38 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 123.618 1.675 . . . . 0.0 109.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -132.69 127.8 35.59 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 5.4 m -74.31 168.23 20.07 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 124.323 2.011 . . . . 0.0 113.822 -168.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 m -52.52 178.32 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.661 -2.518 . . . . 0.0 114.777 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -61.73 -38.55 88.33 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -173.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.62 -52.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 124.351 1.06 . . . . 0.0 108.791 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.68 -41.68 1.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 116.361 1.305 . . . . 0.0 116.361 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -96.17 165.48 12.21 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.469 0.708 . . . . 0.0 109.262 171.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 m120 69.6 72.57 0.24 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 125.967 1.707 . . . . 0.0 107.688 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 17.8 m -71.19 166.64 21.06 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.993 0.902 . . . . 0.0 113.106 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.99 167.34 15.44 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.809 1.29 . . . . 0.0 109.111 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -84.3 155.47 22.39 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.563 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -150.86 136.83 10.85 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.89 127.52 8.66 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 123.683 2.922 . . . . 0.0 112.184 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -86.49 97.32 10.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.873 0.844 . . . . 0.0 109.471 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.96 -69.52 0.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.17 128.3 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.779 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 123.21 23.59 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.57 0.7 . . . . 0.0 109.862 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -132.45 155.76 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.015 0.912 . . . . 0.0 110.753 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.86 -152.48 6.51 Favored Glycine 0 CA--C 1.547 2.067 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.6 tp 59.41 88.79 0.07 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.953 1.701 . . . . 0.0 109.069 -170.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 p -138.91 -77.84 0.35 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.508 -160.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -160.85 124.97 3.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.844 1.202 . . . . 0.0 108.25 -170.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.237 1.97 . . . . 0.0 108.648 169.165 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.34 -62.33 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.794 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 m120 60.32 18.18 7.78 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 126.403 1.881 . . . . 0.0 116.01 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.49 167.66 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 128.354 2.662 . . . . 0.0 112.992 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 17' ' ' THR . 10.3 mm -110.06 93.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 174.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.59 20.23 0.74 Allowed 'General case' 0 CA--C 1.581 2.162 0 O-C-N 120.864 -1.148 . . . . 0.0 113.887 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -120.11 162.74 18.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.361 1.464 . . . . 0.0 114.364 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.03 119.65 39.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 61.29 42.49 11.85 Favored 'General case' 0 CA--C 1.586 2.329 0 CA-C-N 110.784 -2.917 . . . . 0.0 111.112 -168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.0 148.06 19.03 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-O 122.182 0.879 . . . . 0.0 112.598 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -70.32 122.18 19.08 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 123.492 1.615 . . . . 0.0 110.171 -169.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -143.63 -169.82 3.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 111.331 -2.668 . . . . 0.0 109.789 -169.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -150.61 147.01 26.89 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.907 1.337 . . . . 0.0 109.673 -177.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -90.44 106.42 18.49 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.65 72.45 1.29 Allowed Glycine 0 CA--C 1.553 2.424 1 N-CA-C 102.771 -4.132 . . . . 0.0 102.771 -165.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -178.6 -144.83 5.81 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 122.923 1.291 . . . . 0.0 113.425 -165.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.7 m -90.15 136.79 32.83 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 112.594 -1.803 . . . . 0.0 106.563 168.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -106.19 173.73 6.19 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 124.933 2.301 . . . . 0.0 106.217 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.593 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 60.3 m -78.45 140.12 38.66 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-O 124.465 2.079 . . . . 0.0 108.172 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.2 t -47.93 -56.28 7.97 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 110.327 -3.124 . . . . 0.0 117.582 -163.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -92.3 35.33 1.01 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.22 69.71 1.34 Allowed Glycine 0 N--CA 1.483 1.803 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.195 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 77.2 mtp180 -133.74 140.71 37.47 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 112.646 -1.777 . . . . 0.0 109.721 -168.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.9 153.45 32.99 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.245 2.63 . . . . 0.0 113.513 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -111.09 150.4 29.45 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.549 171.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -111.02 -155.18 0.56 Allowed 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 98.4 m -134.85 170.5 15.77 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 123.33 1.538 . . . . 0.0 108.409 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -61.32 175.98 0.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 123.052 1.406 . . . . 0.0 113.163 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.9 mmt -65.38 -34.82 79.22 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -46.9 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.415 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.78 -52.84 0.74 Allowed Glycine 0 N--CA 1.485 1.942 0 CA-C-N 119.729 1.15 . . . . 0.0 113.447 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.3 p -81.87 160.58 23.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.898 0.856 . . . . 0.0 109.735 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.5 m120 66.1 67.71 0.46 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 125.807 1.643 . . . . 0.0 108.525 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.7 m -71.43 164.42 25.83 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.907 -0.495 . . . . 0.0 111.982 -172.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 9.5 mt-10 -140.26 174.36 10.59 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.141 0.496 . . . . 0.0 110.814 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 5.5 t -83.92 161.45 20.82 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.021 0.915 . . . . 0.0 109.512 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -136.68 138.05 25.32 Favored Pre-proline 0 CA--C 1.578 2.029 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.01 133.23 12.22 Favored 'Trans proline' 0 CA--C 1.561 1.831 0 C-N-CA 123.571 2.847 . . . . 0.0 113.415 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -101.02 2.7 40.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -141.47 -75.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 122.247 2.294 . . . . 0.0 108.567 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.22 120.63 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 ptp -72.81 135.52 45.24 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.531 0.681 . . . . 0.0 111.138 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.13 50.78 17.02 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.908 1.683 . . . . 0.0 113.54 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.99 90.82 0.11 Allowed Glycine 0 N--CA 1.479 1.502 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.808 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.44 145.95 28.69 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.095 0.558 . . . . 0.0 110.396 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.3 p -67.99 -51.22 49.75 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.532 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -100.75 95.57 6.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 122.485 1.136 . . . . 0.0 110.727 -170.463 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 64.85 99.97 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.571 1.948 . . . . 0.0 110.394 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.5 t30 58.67 85.38 0.09 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 125.311 2.481 . . . . 0.0 107.848 -170.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 19.8 p -68.24 171.68 6.82 Favored 'General case' 0 CA--C 1.568 1.667 1 CA-C-N 107.513 -4.403 . . . . 0.0 115.514 -168.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG21 ' SG ' ' A' ' 36' ' ' CYS . 40.3 mt -110.53 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.693 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.26 19.9 0.55 Allowed 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.27 166.44 11.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 123.696 1.712 . . . . 0.0 113.831 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.38 120.01 38.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 167.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 66.46 40.08 3.66 Favored 'General case' 0 CA--C 1.589 2.472 0 CA-C-N 110.448 -3.069 . . . . 0.0 111.912 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -94.73 151.42 20.11 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -73.59 119.37 17.72 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.336 1.541 . . . . 0.0 110.713 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 26.7 p -128.45 176.16 7.95 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.197 -2.729 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.13 152.37 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 169.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -83.04 98.92 9.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.33 62.5 0.8 Allowed Glycine 0 CA--C 1.556 2.621 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -167.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.31 -149.95 7.18 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 122.905 1.28 . . . . 0.0 110.344 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -84.03 139.47 32.49 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -98.96 173.65 6.74 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 111.51 -2.586 . . . . 0.0 107.218 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . 49.0 m -91.69 121.53 33.42 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -29.42 -65.5 0.1 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 130.301 3.44 . . . . 0.0 118.476 -164.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttm105 -92.61 38.08 1.01 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.992 1.377 . . . . 0.0 113.899 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.5 43.09 46.1 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 -170.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -90.94 127.31 52.35 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.15 -178.97 4.57 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.635 2.224 . . . . 0.0 112.02 169.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -128.4 146.35 50.81 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 123.227 1.489 . . . . 0.0 109.055 178.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -131.23 128.51 40.06 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.1 m -77.29 167.5 21.62 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 123.11 1.434 . . . . 0.0 113.017 -168.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -71.36 -166.09 0.17 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 123.665 1.698 . . . . 0.0 113.068 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.15 -39.97 93.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 113.364 -1.743 . . . . 0.0 115.381 -171.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.8 mt -73.85 -56.88 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 124.138 0.975 . . . . 0.0 108.421 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.19 -49.78 0.81 Allowed Glycine 0 N--CA 1.484 1.882 0 CA-C-O 119.922 -0.377 . . . . 0.0 113.834 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 p -88.0 156.03 19.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.301 1.048 . . . . 0.0 109.279 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.67 73.81 0.38 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.929 1.692 . . . . 0.0 107.675 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -69.75 168.7 14.46 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.19 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.8 mt-10 -131.54 171.0 13.95 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.145 1.45 . . . . 0.0 110.455 171.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 68.5 m -83.02 161.52 21.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.156 1.382 . . . . 0.0 109.058 -173.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.04 145.83 31.6 Favored Pre-proline 0 CA--C 1.572 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 108.545 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.91 155.98 1.52 Allowed 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 124.467 3.444 . . . . 0.0 115.864 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -70.26 129.26 38.87 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.414 0.626 . . . . 0.0 111.503 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -105.91 88.49 2.82 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.3 tt -94.24 127.27 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -165.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.31 -62.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.685 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 72.96 132.64 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 126.932 2.093 . . . . 0.0 110.047 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.0 82.63 0.06 OUTLIER Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.619 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -145.37 93.31 2.35 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t 64.82 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 126.332 1.853 . . . . 0.0 108.956 -165.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -81.17 143.96 31.99 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.363 0.983 . . . . 0.0 110.462 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.586 2.136 . . . . 0.0 108.653 171.774 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.6 92.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.05 1.74 . . . . 0.0 110.329 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.77 18.54 11.2 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.316 1.846 . . . . 0.0 115.88 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 9.8 p -133.16 176.36 8.57 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.349 1.547 . . . . 0.0 110.819 169.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.9 mt -108.01 97.99 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.06 -8.54 23.99 Favored 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER 30.01 164.21 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.052 2 C-N-CA 132.716 4.407 . . . . 0.0 122.612 167.489 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.7 t70 166.82 100.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 2 CA-C-N 105.264 -5.425 . . . . 0.0 96.961 165.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 49.08 47.6 21.73 Favored 'General case' 0 N--CA 1.499 1.996 1 CA-C-N 106.384 -4.916 . . . . 0.0 110.222 -168.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 171.16 11.99 Favored Glycine 0 C--N 1.364 2.105 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.053 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -93.19 128.81 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 25.3 p -134.11 176.36 8.66 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.824 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.54 153.19 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -84.27 101.8 12.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.28 66.72 1.03 Allowed Glycine 0 CA--C 1.552 2.37 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.11 -152.58 10.35 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 122.988 1.327 . . . . 0.0 110.545 -168.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 m -80.79 142.79 33.39 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 123.31 1.528 . . . . 0.0 107.117 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -116.41 177.94 4.51 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 125.619 2.628 . . . . 0.0 106.327 168.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 19.5 m -78.84 142.04 37.21 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-O 124.644 2.164 . . . . 0.0 108.93 -169.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -51.98 -48.84 64.21 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 110.033 -3.258 . . . . 0.0 116.623 -163.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -90.49 37.58 0.91 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 123.142 1.449 . . . . 0.0 113.84 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 58.13 11.27 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 114.166 -1.379 . . . . 0.0 115.121 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.36 144.25 41.43 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 113.489 -1.355 . . . . 0.0 110.744 -169.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.62 178.99 6.07 Favored 'Trans proline' 0 CA--C 1.566 2.092 0 C-N-CA 123.408 2.739 . . . . 0.0 114.674 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.5 142.31 30.16 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.847 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -148.81 134.31 18.61 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 m -73.23 164.68 26.33 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 124.586 2.136 . . . . 0.0 114.031 -168.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 t -63.72 -165.25 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 110.73 -2.941 . . . . 0.0 113.656 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -43.61 87.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.359 -1.746 . . . . 0.0 114.81 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.84 -37.5 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.808 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.78 -39.15 2.09 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -103.76 162.49 13.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.697 0.799 . . . . 0.0 109.239 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.4 m120 68.09 75.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.953 1.701 . . . . 0.0 107.099 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 33.8 m -69.66 161.46 29.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.46 0.648 . . . . 0.0 112.376 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 33.9 mt-10 -119.27 172.35 7.66 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 124.614 2.15 . . . . 0.0 108.555 168.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 41.1 t -92.09 141.37 28.68 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.341 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.4 p -103.41 113.86 65.35 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.67 -37.17 70.69 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.837 3.025 . . . . 0.0 117.21 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 40.56 68.63 0.39 Allowed 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.976 2.11 . . . . 0.0 112.939 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.51 -39.89 15.81 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.047 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.7 mm 67.17 93.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 126.562 1.945 . . . . 0.0 107.926 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.0 ttm 61.98 -94.33 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 126.549 1.939 . . . . 0.0 110.109 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 70.92 134.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.115 2.166 . . . . 0.0 110.075 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.89 96.63 1.43 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.932 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -22.09 61.41 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.6 p -91.54 108.21 19.74 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.891 1.678 . . . . 0.0 108.187 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -99.39 -66.32 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.719 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.121 1.915 . . . . 0.0 109.543 178.701 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.0 -65.44 1.02 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -149.87 75.35 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 126.266 2.936 . . . . 0.0 107.133 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 22.7 p -160.07 165.27 32.14 Favored 'General case' 0 CA--C 1.567 1.621 1 CA-C-N 107.628 -4.351 . . . . 0.0 109.987 172.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' SG ' ' A' ' 36' ' ' CYS . 16.6 mt -114.72 90.63 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 21.2 0.72 Allowed 'General case' 0 CA--C 1.578 2.033 0 O-C-N 120.628 -1.295 . . . . 0.0 114.037 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.38 157.24 16.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 123.27 1.51 . . . . 0.0 114.145 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.25 122.62 46.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 167.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 53.86 44.03 30.08 Favored 'General case' 0 CA--C 1.592 2.568 0 CA-C-N 109.65 -3.432 . . . . 0.0 111.908 -169.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -67.66 -175.22 8.26 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 126.056 1.789 . . . . 0.0 114.368 168.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -97.27 130.1 44.5 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 168.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.6 p -134.96 176.62 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.372 1.069 . . . . 0.0 110.047 169.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.36 155.13 44.35 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 123.233 1.492 . . . . 0.0 108.798 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -79.42 104.38 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.05 67.57 1.3 Allowed Glycine 0 CA--C 1.551 2.299 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -167.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.3 -153.81 9.94 Favored Glycine 0 N--CA 1.478 1.462 0 CA-C-O 123.112 1.395 . . . . 0.0 110.525 -168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -85.03 142.9 29.25 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -102.88 176.72 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.853 -2.43 . . . . 0.0 106.587 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 23' ' ' ARG . 44.2 m -88.58 131.17 35.06 Favored 'General case' 0 CA--C 1.577 1.993 0 CA-C-O 124.084 1.897 . . . . 0.0 106.613 -168.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.1 t -45.05 -51.45 10.06 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -90.8 36.51 0.9 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 123.141 1.448 . . . . 0.0 113.378 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.34 57.46 13.16 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.082 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 16.8 mmm180 -115.58 132.34 23.19 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 113.657 -1.271 . . . . 0.0 107.593 -169.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.86 -168.46 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 123.308 2.672 . . . . 0.0 113.023 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -138.25 130.99 29.52 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -105.3 121.45 43.89 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 85.4 m -80.03 170.24 16.73 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 123.259 1.504 . . . . 0.0 112.603 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -60.34 -179.39 0.11 Allowed 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 113.954 -1.475 . . . . 0.0 113.393 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 78.6 mtp -64.8 -35.86 82.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 pt -74.87 -45.36 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-O 118.062 -0.971 . . . . 0.0 111.292 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.85 -52.97 0.77 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 119.862 1.21 . . . . 0.0 113.706 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -86.3 163.81 17.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.831 0.824 . . . . 0.0 109.375 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 64.33 66.79 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 125.382 1.473 . . . . 0.0 108.678 -171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 84.5 m -74.75 175.63 7.78 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.067 0.937 . . . . 0.0 112.281 -171.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 26.9 mt-10 -124.6 169.75 11.62 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.509 169.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 14.6 m -86.0 162.5 18.47 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 123.67 0.788 . . . . 0.0 109.705 -173.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.94 165.95 0.13 Allowed Pre-proline 0 CA--C 1.591 2.536 0 C-N-CA 124.836 1.255 . . . . 0.0 111.041 169.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.39 168.93 18.18 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.779 3.653 . . . . 0.0 115.272 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -90.71 81.53 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.8 tp -173.1 114.66 0.25 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -98.1 69.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 123.064 1.412 . . . . 0.0 108.206 173.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 ttt -165.69 90.5 0.47 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -139.89 141.7 36.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.913 0.863 . . . . 0.0 109.604 -162.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.72 -77.31 0.84 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.925 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.61 104.44 12.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.2 p -151.85 116.52 5.12 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.498 0.666 . . . . 0.0 109.557 -166.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -153.27 139.5 18.43 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 124.577 2.132 . . . . 0.0 109.07 173.184 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -103.21 108.2 19.32 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 179.04 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.8 p -144.02 170.63 15.56 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 111.607 -2.542 . . . . 0.0 111.123 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.5 mt -110.99 86.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.62 20.64 0.71 Allowed 'General case' 0 CA--C 1.583 2.228 0 O-C-N 120.63 -1.294 . . . . 0.0 113.84 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -103.44 160.32 14.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.419 1.488 . . . . 0.0 114.688 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.56 121.21 41.91 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 168.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 52.9 40.13 30.35 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.176 -167.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.66 141.99 22.34 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.121 -0.987 . . . . 0.0 112.255 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -73.3 125.82 28.7 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 125.167 2.413 . . . . 0.0 107.385 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -139.66 -178.42 5.4 Favored 'General case' 0 N--CA 1.479 1.021 1 CA-C-N 108.026 -4.17 . . . . 0.0 110.818 -169.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 m -145.26 162.59 36.8 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 124.526 2.108 . . . . 0.0 108.526 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -94.79 93.96 7.8 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 111.808 -2.451 . . . . 0.0 106.035 168.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.93 -39.26 2.52 Favored Glycine 0 CA--C 1.552 2.368 0 CA-C-O 119.683 -0.51 . . . . 0.0 113.73 -168.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.86 -148.68 0.1 OUTLIER Glycine 0 CA--C 1.541 1.705 0 CA-C-O 122.554 1.086 . . . . 0.0 114.758 169.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -73.69 140.86 46.33 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 123.411 1.576 . . . . 0.0 107.475 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -107.33 -179.76 4.02 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.242 -2.254 . . . . 0.0 106.587 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 18.2 m -80.47 143.1 33.63 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 124.686 2.184 . . . . 0.0 108.445 -170.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.9 t -50.07 -51.17 44.7 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 110.053 -3.249 . . . . 0.0 117.623 -163.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 122.706 1.241 . . . . 0.0 114.274 -171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.85 67.03 2.16 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.816 -170.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 69.3 mtp180 -127.42 134.85 26.61 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-N 112.823 -1.689 . . . . 0.0 109.458 -168.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.02 173.56 13.8 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 123.068 2.512 . . . . 0.0 113.891 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -128.94 145.88 51.11 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.396 174.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -130.63 136.35 48.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.8 m -74.69 166.73 23.1 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 124.47 2.081 . . . . 0.0 114.13 -168.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -63.04 -165.26 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.647 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.2 ptm -59.91 -37.19 78.72 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.79 -52.3 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 124.62 1.168 . . . . 0.0 109.057 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.95 -39.81 1.8 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-O 119.366 -0.685 . . . . 0.0 114.72 -169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.1 p -108.01 161.9 14.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 69.77 76.58 0.21 Allowed 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.933 1.693 . . . . 0.0 106.965 -171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 20.8 m -73.47 171.43 13.15 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 7.0 mt-10 -130.38 170.03 14.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.684 1.23 . . . . 0.0 109.186 168.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.8 t -81.86 150.75 27.64 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.776 0.83 . . . . 0.0 109.483 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.2 p -87.14 122.83 70.84 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.567 172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.63 -59.98 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.037 3.158 . . . . 0.0 115.344 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 49.86 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 128.805 2.842 . . . . 0.0 114.744 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 tt 69.56 104.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 126.382 1.873 . . . . 0.0 109.477 169.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.11 135.05 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.0 ttt -86.49 108.08 18.37 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.51 131.0 57.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.49 81.31 1.33 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.762 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mp -93.75 -69.97 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -91.77 -69.08 0.76 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -149.18 106.86 3.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 124.304 2.002 . . . . 0.0 108.371 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 121.658 0.742 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.0 82.58 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.74 19.99 4.78 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 16.8 p 55.97 169.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 C-N-CA 128.167 2.587 . . . . 0.0 112.854 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 63.6 mt -114.01 97.26 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.1 20.21 0.51 Allowed 'General case' 0 CA--C 1.584 2.283 0 O-C-N 119.169 -2.207 . . . . 0.0 114.041 -174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -118.01 163.42 16.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.66 1.695 . . . . 0.0 115.527 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.36 124.67 51.36 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 100.563 -3.866 . . . . 0.0 100.563 167.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 63.2 33.29 14.42 Favored 'General case' 0 CA--C 1.587 2.398 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.657 -169.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -87.49 147.23 20.54 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 167.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -74.99 124.79 27.61 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 123.644 1.688 . . . . 0.0 108.956 -169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.3 p -135.99 176.8 8.35 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.146 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.8 154.22 42.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 123.184 1.469 . . . . 0.0 107.218 169.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.36 101.98 11.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.25 64.13 0.94 Allowed Glycine 0 CA--C 1.553 2.467 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -167.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.92 -151.84 9.34 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -168.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -86.0 138.79 31.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -116.17 -179.88 3.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 6.3 m -81.54 143.06 32.29 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 126.618 3.104 . . . . 0.0 109.512 -168.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -48.1 -50.55 28.02 Favored 'General case' 0 CA--C 1.556 1.179 1 CA-C-N 106.441 -4.89 . . . . 0.0 116.631 -163.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -91.39 35.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.753 1.264 . . . . 0.0 114.086 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.42 63.56 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.236 -172.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 27.4 mmm-85 -123.13 130.27 24.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.172 -1.514 . . . . 0.0 109.168 -168.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 173.38 14.17 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.165 2.576 . . . . 0.0 114.135 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -124.86 145.19 49.92 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 123.563 1.649 . . . . 0.0 109.315 178.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -132.0 130.62 41.65 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.0 m -73.52 165.88 24.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 124.228 1.966 . . . . 0.0 113.813 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -62.88 -164.64 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 111.522 -2.581 . . . . 0.0 113.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 31.1 ttp -67.07 -41.82 85.74 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.035 -172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.82 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.874 -177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.48 -44.93 1.15 Allowed Glycine 0 N--CA 1.488 2.102 0 CA-C-N 119.859 1.209 . . . . 0.0 115.074 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 162.15 13.2 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.769 0.795 . . . . 0.0 109.203 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 67.67 76.23 0.28 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 125.76 1.624 . . . . 0.0 107.143 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 18.4 m -70.09 168.08 16.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 121.82 0.819 . . . . 0.0 112.93 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.3 mt-10 -125.05 171.92 9.87 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.001 1.382 . . . . 0.0 107.833 168.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -86.4 163.67 17.47 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.577 1.18 . . . . 0.0 108.673 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -144.03 138.51 15.07 Favored Pre-proline 0 CA--C 1.571 1.768 0 O-C-N 121.137 -0.977 . . . . 0.0 108.872 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.28 161.69 34.7 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.372 2.715 . . . . 0.0 113.549 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.54 107.41 6.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 79.94 114.14 0.06 Allowed 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -88.46 103.48 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -160.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 tpt -154.65 111.19 3.27 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -95.68 133.71 39.45 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.068 0.937 . . . . 0.0 109.276 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.65 -107.85 1.07 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.178 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.98 -64.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.024 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.2 p -79.93 135.84 36.51 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.463 0.705 . . . . 0.0 110.423 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -76.69 -75.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 117.747 -1.12 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.615 1.197 . . . . 0.0 110.889 179.196 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.555 1.143 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.81 111.43 5.73 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 58.2 23.28 10.1 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.2 p -142.73 176.93 8.67 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.391 1.077 . . . . 0.0 110.998 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mt -112.54 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.78 -4.81 10.0 Favored 'General case' 0 CA--C 1.594 2.672 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 27.77 154.41 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.765 2 C-N-CA 133.058 4.543 . . . . 0.0 122.901 167.115 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.32 98.4 0.1 Allowed 'General case' 0 N--CA 1.485 1.313 2 N-CA-C 95.66 -5.681 . . . . 0.0 95.66 164.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 47.34 43.83 15.57 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.658 -166.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.1 158.64 53.15 Favored Glycine 0 C--N 1.363 2.028 0 CA-C-O 122.005 0.781 . . . . 0.0 113.114 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -90.88 123.94 34.79 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.84 177.37 7.78 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 112.433 -2.167 . . . . 0.0 111.277 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 153.1 41.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -84.63 100.35 11.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.35 62.96 0.83 Allowed Glycine 0 CA--C 1.555 2.577 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -167.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.76 -152.82 9.79 Favored Glycine 0 N--CA 1.48 1.591 0 CA-C-O 122.899 1.277 . . . . 0.0 109.932 -168.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 142.78 30.42 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -111.25 178.0 4.48 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 125.264 2.459 . . . . 0.0 106.385 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -82.78 138.11 34.12 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 124.741 2.21 . . . . 0.0 109.202 -169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -47.86 -53.55 15.32 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 109.413 -3.54 . . . . 0.0 116.353 -164.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -92.24 34.96 1.01 Allowed 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.75 1.262 . . . . 0.0 114.245 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.44 64.27 2.67 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 114.548 -1.205 . . . . 0.0 114.504 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -127.99 132.69 24.48 Favored Pre-proline 0 CA--C 1.578 2.029 0 CA-C-N 113.472 -1.364 . . . . 0.0 109.049 -169.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.22 -177.71 3.86 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.614 2.876 . . . . 0.0 114.026 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -129.53 154.23 47.24 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 123.462 1.601 . . . . 0.0 110.096 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -135.66 119.29 17.07 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 69.9 m -76.4 168.96 19.13 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 123.098 1.428 . . . . 0.0 112.861 -168.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.47 179.03 0.17 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 123.134 1.445 . . . . 0.0 113.689 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -41.36 97.98 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -170.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.45 -38.08 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.019 0 C-N-CA 124.127 0.971 . . . . 0.0 111.668 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.98 -46.94 1.05 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 119.456 1.025 . . . . 0.0 114.348 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 p -85.05 160.88 19.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.089 0.947 . . . . 0.0 109.505 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 65.18 65.99 0.56 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.746 1.619 . . . . 0.0 108.876 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.5 m -71.31 158.27 36.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.984 -0.447 . . . . 0.0 111.869 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -124.45 170.17 11.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 124.663 2.173 . . . . 0.0 108.73 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.9 t -95.58 157.2 16.0 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.677 -170.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.5 p -94.13 121.52 63.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -48.84 -54.42 5.43 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.916 3.078 . . . . 0.0 115.055 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -152.32 -76.5 0.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.84 132.2 54.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pp -91.23 98.01 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.12 127.27 10.5 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -98.37 131.27 44.8 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.43 80.85 1.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.405 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.7 tp 61.26 -97.47 0.07 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.277 1.831 . . . . 0.0 110.038 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 134.79 14.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.338 1.426 . . . . 0.0 109.243 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -138.35 113.46 9.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.618 1.199 . . . . 0.0 110.535 -179.213 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -112.03 96.12 5.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.373 -1.344 . . . . 0.0 107.373 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 t30 175.78 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 31.9 p -125.49 171.16 10.73 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 108.636 -3.893 . . . . 0.0 110.772 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 15.5 mm -105.17 98.57 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 174.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.89 10.09 2.49 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 119.849 -1.782 . . . . 0.0 114.502 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -137.46 143.04 41.58 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -75.19 132.58 41.24 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 56.96 33.63 23.59 Favored 'General case' 0 CA--C 1.589 2.45 0 CA-C-N 111.457 -2.61 . . . . 0.0 111.918 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.93 149.86 21.84 Favored Glycine 0 C--N 1.36 1.896 0 CA-C-O 122.971 1.317 . . . . 0.0 109.961 168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 123.45 25.01 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 123.685 1.707 . . . . 0.0 108.805 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.4 p -142.17 -166.31 2.21 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 111.815 -2.448 . . . . 0.0 110.229 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.424 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -140.16 144.59 36.73 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.837 -1.529 . . . . 0.0 108.356 172.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -90.39 107.22 19.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.2 73.0 1.27 Allowed Glycine 0 CA--C 1.553 2.468 1 N-CA-C 102.482 -4.247 . . . . 0.0 102.482 -165.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . 177.64 -141.87 5.42 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 122.831 1.239 . . . . 0.0 112.243 -165.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -89.93 137.54 32.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 167.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -119.04 177.99 4.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 125.165 2.412 . . . . 0.0 104.969 167.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -72.14 142.12 49.12 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 126.56 3.076 . . . . 0.0 111.099 -168.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -49.37 -55.83 11.62 Favored 'General case' 0 CA--C 1.557 1.243 1 CA-C-N 106.131 -5.031 . . . . 0.0 116.061 -164.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -92.45 36.59 1.0 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.799 1.285 . . . . 0.0 114.079 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.3 63.38 2.26 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.957 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.99 136.04 26.93 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 113.434 -1.383 . . . . 0.0 108.771 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.23 159.63 36.71 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 122.936 2.424 . . . . 0.0 113.868 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -110.46 152.21 26.59 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 123.249 1.5 . . . . 0.0 108.729 169.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -145.61 131.75 19.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.5 m -77.26 175.05 10.07 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-O 123.316 1.531 . . . . 0.0 113.572 -168.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -52.51 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 126.246 1.819 . . . . 0.0 114.435 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.4 mtm -62.19 -42.82 99.64 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 123.66 0.784 . . . . 0.0 112.759 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.98 -35.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.803 169.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.5 62.08 1.58 Allowed Glycine 0 N--CA 1.479 1.561 0 CA-C-N 119.7 1.137 . . . . 0.0 113.749 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.5 m -151.79 -33.62 0.14 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -114.68 53.84 0.79 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 126.404 1.882 . . . . 0.0 110.604 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 61.9 m -53.44 152.54 4.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -137.83 172.29 13.17 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.451 1.119 . . . . 0.0 110.501 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m -86.69 155.8 20.24 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.683 1.23 . . . . 0.0 109.637 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -142.09 132.2 12.58 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.42 85.93 1.22 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.643 2.895 . . . . 0.0 112.331 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 63.02 113.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 126.385 1.874 . . . . 0.0 109.208 -169.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -78.11 128.23 33.5 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.5 pt -84.99 131.44 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.129 0.966 . . . . 0.0 108.801 -170.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.33 116.52 25.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -123.72 136.59 54.54 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.035 0.921 . . . . 0.0 109.116 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.477 1.414 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.27 90.24 5.78 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 167.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -131.43 68.98 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.918 0.866 . . . . 0.0 108.86 173.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.03 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.768 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.198 1.951 . . . . 0.0 108.606 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.94 -57.97 0.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.577 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -137.73 9.18 2.85 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 30.5 p -147.05 169.51 19.1 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.393 1.077 . . . . 0.0 110.876 172.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' HB ' ' A' ' 17' ' ' THR . 7.9 mm -105.46 94.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.98 19.65 0.86 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -118.04 164.72 14.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.148 1.379 . . . . 0.0 112.612 -170.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -112.9 120.89 42.99 Favored 'General case' 0 N--CA 1.485 1.308 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 167.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 58.6 48.94 11.07 Favored 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.413 -167.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.27 -170.92 28.33 Favored Glycine 0 N--CA 1.486 2.029 0 C-N-CA 125.258 1.409 . . . . 0.0 113.885 168.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 5' ' ' ILE . 15.3 pttp -97.66 131.69 44.0 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 167.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 9.0 p -147.9 -173.73 4.37 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.045 1.402 . . . . 0.0 110.709 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -144.88 145.11 31.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.251 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 43.2 m0 -90.65 114.32 26.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 168.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 69.01 1.43 Allowed Glycine 0 CA--C 1.556 2.652 1 N-CA-C 102.687 -4.165 . . . . 0.0 102.687 -165.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 13' ' ' THR . . . -177.38 -145.04 5.63 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 123.181 1.434 . . . . 0.0 112.314 -165.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.655 ' HB ' HD11 ' A' ' 5' ' ' ILE . 1.4 m -91.29 137.52 32.3 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 112.454 -1.873 . . . . 0.0 108.391 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 174.0 6.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 125.062 2.363 . . . . 0.0 106.448 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 85.3 m -77.88 138.86 39.14 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 124.338 2.018 . . . . 0.0 109.232 -169.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.7 t -49.23 -54.31 17.34 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 110.235 -3.166 . . . . 0.0 117.205 -164.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -91.65 33.7 1.01 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -170.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.7 67.22 1.83 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.477 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 19' ' ' CYS . 28.9 mmt180 -138.49 144.83 44.1 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 113.517 -1.342 . . . . 0.0 109.953 -169.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.89 158.42 34.76 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 123.119 2.546 . . . . 0.0 113.826 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 138.31 51.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -136.41 132.14 35.08 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.3 m -74.62 165.57 25.0 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 123.193 1.473 . . . . 0.0 113.332 -168.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -65.68 -167.57 0.04 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.678 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.16 -34.56 76.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.356 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -74.7 -51.5 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 124.081 0.952 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.11 45.15 5.15 Favored Glycine 0 CA--C 1.55 2.266 0 N-CA-C 115.721 1.048 . . . . 0.0 115.721 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.6 m -159.19 -34.51 0.06 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 125.355 1.462 . . . . 0.0 113.652 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.14 59.51 0.63 Allowed 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 126.989 2.116 . . . . 0.0 108.413 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 79.1 m -57.05 167.06 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.926 1.29 . . . . 0.0 113.457 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.554 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.1 mt-10 -131.79 177.21 7.7 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.219 1.009 . . . . 0.0 112.088 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.63 161.58 23.41 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.531 1.158 . . . . 0.0 108.687 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -144.4 140.77 17.06 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.5 73.15 5.26 Favored 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 123.396 2.731 . . . . 0.0 113.599 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 mtp-105 47.21 70.75 0.38 Allowed 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 125.923 1.689 . . . . 0.0 111.764 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.9 tp -157.38 108.62 2.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -88.57 124.27 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.4 ptm -102.95 100.17 10.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -152.27 136.83 16.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.88 99.69 2.56 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-N 114.57 -1.195 . . . . 0.0 112.523 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.37 127.92 10.76 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -94.33 -69.79 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.677 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -95.34 -67.07 0.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.57 0.748 . . . . 0.0 109.884 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 124.612 2.149 . . . . 0.0 110.331 -173.07 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.562 1.418 0 CA-C-O 122.178 0.989 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -140.22 -91.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 174.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -95.27 2.62 54.87 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 169.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 24.5 p -159.06 165.86 32.96 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 125.843 1.657 . . . . 0.0 108.775 169.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 58.7 mt -106.65 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.66 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.88 21.47 0.55 Allowed 'General case' 0 CA--C 1.585 2.323 0 O-C-N 119.482 -2.011 . . . . 0.0 113.789 -176.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -113.11 164.99 12.8 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -111.44 123.93 51.22 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 100.634 -3.839 . . . . 0.0 100.634 168.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 58.94 32.78 22.58 Favored 'General case' 0 CA--C 1.591 2.523 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.456 -168.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 146.17 23.87 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 120.701 -1.249 . . . . 0.0 110.31 168.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 115.16 15.23 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 123.871 1.796 . . . . 0.0 108.919 -169.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -121.43 177.23 5.28 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 110.584 -3.007 . . . . 0.0 110.127 -179.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.77 152.53 43.84 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 169.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -83.68 97.83 9.32 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 62.71 0.76 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -167.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.05 -155.08 12.34 Favored Glycine 0 N--CA 1.481 1.676 0 CA-C-O 122.691 1.161 . . . . 0.0 110.349 -168.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.21 139.2 35.65 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.35 177.66 4.58 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 112.106 -2.315 . . . . 0.0 105.858 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 3.3 m -77.69 142.86 38.54 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 126.395 2.997 . . . . 0.0 109.49 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -45.93 -51.17 13.71 Favored 'General case' 0 CA--C 1.554 1.123 1 CA-C-N 106.667 -4.788 . . . . 0.0 117.078 -163.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.23 37.39 0.94 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.823 1.297 . . . . 0.0 113.642 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 57.97 11.34 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.349 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -116.26 132.95 23.02 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-N 113.742 -1.229 . . . . 0.0 109.238 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.52 176.21 10.37 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.167 2.578 . . . . 0.0 113.805 -175.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -127.58 146.39 50.55 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 123.145 1.45 . . . . 0.0 109.227 -179.583 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -125.21 125.63 43.93 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.8 m -78.31 164.28 24.99 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.926 1.346 . . . . 0.0 113.017 -168.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -77.86 -171.39 2.24 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 123.668 1.699 . . . . 0.0 112.867 -173.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -63.32 -14.52 50.71 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.3 mt -127.96 89.24 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.463 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 169.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.99 -29.26 19.88 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-N 111.967 -2.379 . . . . 0.0 116.46 -176.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -83.38 124.54 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 166.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 88.88 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 -166.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.04 172.05 11.75 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.813 176.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -131.49 170.38 14.78 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 122.573 1.178 . . . . 0.0 110.614 169.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -90.71 160.48 15.81 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.436 1.094 . . . . 0.0 110.66 -169.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.6 p -103.77 121.61 47.51 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.713 -0.661 . . . . 0.0 110.342 -169.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -52.84 157.38 7.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 124.607 3.538 . . . . 0.0 116.575 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -140.53 126.98 20.04 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 43.02 -157.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 127.467 2.307 . . . . 0.0 114.029 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm 74.04 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 C-N-CA 126.869 2.068 . . . . 0.0 107.546 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 ptm -114.2 165.71 12.39 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.408 1.099 . . . . 0.0 110.063 164.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.02 141.38 43.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.793 0.806 . . . . 0.0 110.831 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.32 -103.67 3.05 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.036 -175.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.1 mt -94.38 118.71 32.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.8 m -80.11 118.87 22.2 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.181 0.515 . . . . 0.0 110.608 -170.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -135.1 -75.66 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 124.118 1.914 . . . . 0.0 108.288 -178.112 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 CA--C 1.558 1.279 0 CA-C-O 118.345 -0.836 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.47 90.28 0.06 Allowed 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 126.271 1.829 . . . . 0.0 109.555 -173.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -102.28 -77.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.763 0.792 . . . . 0.0 109.331 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 29.4 p -125.09 174.13 8.25 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.972 172.01 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 22.0 mt -107.74 99.05 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 175.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.94 18.1 0.52 Allowed 'General case' 0 CA--C 1.587 2.377 0 O-C-N 119.758 -1.839 . . . . 0.0 113.83 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -130.15 135.59 48.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.093 1.357 . . . . 0.0 114.652 -169.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.36 125.74 30.75 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 167.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 60.51 43.34 13.1 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 111.159 -2.746 . . . . 0.0 111.629 -169.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -78.46 -167.33 31.37 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 125.321 1.439 . . . . 0.0 109.938 167.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.34 130.73 40.54 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.607 -0.937 . . . . 0.0 108.62 168.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 7.1 p -135.46 -179.41 5.62 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.858 176.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.7 149.08 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 123.677 1.703 . . . . 0.0 107.441 168.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.35 99.92 11.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 169.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.56 68.39 1.2 Allowed Glycine 0 CA--C 1.561 2.938 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 -164.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.84 -154.6 8.49 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 122.45 1.028 . . . . 0.0 113.349 -166.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -90.45 147.8 23.18 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 167.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -117.26 174.38 6.16 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 124.639 2.161 . . . . 0.0 106.283 168.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 1.8 m -73.32 143.29 47.0 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 126.476 3.036 . . . . 0.0 110.045 -176.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.4 t -50.76 -50.48 55.64 Favored 'General case' 0 CA--C 1.56 1.355 1 CA-C-N 106.316 -4.947 . . . . 0.0 115.646 -164.032 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.67 36.65 0.95 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.924 1.345 . . . . 0.0 114.176 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.83 60.55 4.87 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-N 114.641 -1.163 . . . . 0.0 115.26 177.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -127.07 114.96 21.88 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 113.403 -1.399 . . . . 0.0 107.734 -169.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -59.31 161.6 16.41 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.497 2.798 . . . . 0.0 115.561 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 150.28 31.71 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 123.69 1.709 . . . . 0.0 107.989 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -144.41 125.52 14.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 78.9 m -74.49 171.55 13.58 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.712 1.244 . . . . 0.0 112.861 -168.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 t -63.42 -170.52 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 123.721 1.724 . . . . 0.0 112.865 175.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.0 mmt -71.88 -39.82 69.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.392 -170.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -36.97 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.101 0 CA-C-O 117.862 -1.066 . . . . 0.0 112.272 175.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.34 -47.45 1.02 Allowed Glycine 0 N--CA 1.488 2.134 0 CA-C-N 120.114 1.325 . . . . 0.0 114.079 -172.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -80.5 174.88 11.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.928 0.87 . . . . 0.0 109.85 169.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 56.31 57.22 5.11 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 127.155 2.182 . . . . 0.0 110.798 -176.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 78.4 m -66.04 158.23 28.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.925 -169.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 28.8 mt-10 -130.97 178.85 6.36 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.687 1.232 . . . . 0.0 111.877 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -88.08 160.05 17.98 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.337 -0.852 . . . . 0.0 109.505 177.422 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -144.44 136.52 13.13 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 121.177 -0.952 . . . . 0.0 109.232 174.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.06 88.49 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 123.963 3.109 . . . . 0.0 113.061 -176.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -90.35 123.24 33.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.768 -169.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.2 mt -72.92 -56.5 5.08 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.076 174.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.81 111.03 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 163.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.6 ttt -64.16 -41.23 97.23 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.22 134.15 44.22 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.047 0.84 . . . . 0.0 110.766 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.23 -153.38 14.37 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 122.128 0.849 . . . . 0.0 112.616 178.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.7 tp -147.81 -70.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -103.12 91.35 4.07 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -139.91 125.53 19.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 122.42 1.105 . . . . 0.0 110.601 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -133.41 121.66 22.61 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 171.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -100.19 17.26 21.72 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 32.1 p -141.56 169.41 17.66 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 124.825 1.25 . . . . 0.0 110.487 172.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 16.3 mt -108.8 96.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.65 -6.38 11.12 Favored 'General case' 0 N--CA 1.512 2.656 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -177.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 25.25 161.32 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.783 2 N-CA-C 123.847 4.758 . . . . 0.0 123.847 166.799 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.27 96.99 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.286 2 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 163.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 44.26 50.13 7.76 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.643 -166.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.41 172.9 5.74 Favored Glycine 0 N--CA 1.486 2.024 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.799 171.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -93.32 135.11 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.755 1.74 . . . . 0.0 106.718 169.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 18.3 p -136.42 178.24 7.22 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 110.42 -3.082 . . . . 0.0 111.109 176.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 150.0 36.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 168.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -84.56 101.97 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.87 65.92 0.96 Allowed Glycine 0 CA--C 1.553 2.461 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -167.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.11 -150.65 9.07 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -168.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -80.99 139.3 35.87 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 169.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -106.48 175.81 5.38 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 111.289 -2.687 . . . . 0.0 105.735 168.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 65.5 m -79.93 149.81 30.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.321 -169.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.3 t -65.07 179.31 0.71 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.453 -166.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 2.67 58.53 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 129.993 3.317 . . . . 0.0 116.903 -166.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.11 62.22 2.83 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 108.628 -3.896 . . . . 0.0 117.652 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -125.06 145.68 51.17 Favored Pre-proline 0 CA--C 1.591 2.524 0 O-C-N 124.358 0.681 . . . . 0.0 110.618 -178.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.61 171.08 6.29 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 C-N-CA 124.27 3.314 . . . . 0.0 114.92 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 147.89 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.164 1.459 . . . . 0.0 108.482 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -147.48 127.9 14.01 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -174.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.1 m -74.91 170.79 15.24 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 122.836 1.303 . . . . 0.0 112.558 -168.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.7 t -66.61 -170.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.902 1.811 . . . . 0.0 113.445 -174.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -66.89 -42.79 84.92 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 113.264 -1.789 . . . . 0.0 114.644 -172.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.18 -56.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 124.112 0.965 . . . . 0.0 108.696 172.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.88 -47.57 0.69 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 114.524 0.57 . . . . 0.0 114.524 -171.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.6 p -84.22 158.48 21.26 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.517 1.151 . . . . 0.0 109.75 174.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.8 65.0 0.24 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.056 1.742 . . . . 0.0 108.757 -175.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 77.9 m -65.91 153.29 42.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.666 -0.647 . . . . 0.0 111.155 -171.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 30.4 mt-10 -121.57 172.97 7.71 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 124.407 2.051 . . . . 0.0 109.94 176.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.641 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 16.0 t -92.21 162.63 14.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.353 176.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -128.15 129.03 23.69 Favored Pre-proline 0 CA--C 1.575 1.942 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 167.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.56 102.42 1.4 Allowed 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.138 2.559 . . . . 0.0 112.454 -171.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -101.04 88.35 3.5 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 83.25 2.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 169.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.4 pt 34.84 69.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 C-N-CA 126.977 2.111 . . . . 0.0 111.825 -158.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 52.0 mtt -127.9 89.05 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -167.86 149.29 5.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.865 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.55 -77.88 0.59 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.965 169.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -143.18 116.05 8.79 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m 67.84 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.497 1.919 . . . . 0.0 110.243 174.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -152.42 129.53 11.13 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.133 1.921 . . . . 0.0 108.951 170.07 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.95 87.33 0.09 Allowed 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 126.078 1.751 . . . . 0.0 110.072 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 179.17 92.95 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 171.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.5 p -111.33 176.24 5.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 111.788 -2.46 . . . . 0.0 111.66 -171.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 56.1 mt -107.48 94.68 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.43 17.86 0.62 Allowed 'General case' 0 CA--C 1.58 2.115 0 O-C-N 119.927 -1.733 . . . . 0.0 114.087 -175.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.27 142.35 51.17 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -169.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -82.33 131.57 35.23 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 167.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 59.37 30.11 19.77 Favored 'General case' 0 CA--C 1.591 2.54 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.426 -169.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.93 150.69 25.34 Favored Glycine 0 C--N 1.362 2.022 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 167.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.12 124.65 27.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 123.458 1.599 . . . . 0.0 109.05 -169.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -135.36 175.35 9.67 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 111.215 -2.72 . . . . 0.0 110.646 -173.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 153.07 40.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -83.82 101.22 11.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 168.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 61.93 0.85 Allowed Glycine 0 CA--C 1.556 2.648 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -167.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.81 -153.83 11.21 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -168.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 m -84.76 141.17 30.72 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -114.07 177.51 4.61 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 124.566 2.127 . . . . 0.0 106.167 168.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.0 m -79.57 141.03 36.97 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 126.334 2.969 . . . . 0.0 109.417 -172.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 4.0 t -46.53 -50.65 16.85 Favored 'General case' 0 CA--C 1.559 1.299 1 CA-C-N 106.673 -4.785 . . . . 0.0 116.273 -164.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.52 34.7 0.96 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -177.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.62 61.31 5.42 Favored Glycine 0 N--CA 1.483 1.809 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.008 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -123.65 128.21 25.25 Favored Pre-proline 0 CA--C 1.569 1.692 0 CA-C-N 113.505 -1.347 . . . . 0.0 108.603 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.92 -176.19 3.04 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 123.375 2.717 . . . . 0.0 113.629 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -126.5 146.26 50.18 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 123.533 1.635 . . . . 0.0 109.868 -178.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -120.99 120.49 35.58 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 63.8 m -75.78 167.88 21.07 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 122.964 1.364 . . . . 0.0 112.706 -168.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -71.23 -165.46 0.13 Allowed 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 123.634 1.683 . . . . 0.0 113.032 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -66.3 -41.95 89.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 113.41 -1.723 . . . . 0.0 115.05 -169.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.8 mt -74.21 -58.06 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.85 -50.92 0.66 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-O 119.888 -0.396 . . . . 0.0 114.001 -169.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -86.35 155.64 20.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.362 1.077 . . . . 0.0 109.383 172.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.2 72.95 0.42 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.935 1.694 . . . . 0.0 107.755 -169.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 76.7 m -68.21 168.13 12.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.168 -177.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.5 mt-10 -129.59 171.75 12.29 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 122.593 1.187 . . . . 0.0 109.638 169.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.3 m -88.15 163.2 16.3 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.362 1.077 . . . . 0.0 109.756 -170.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -145.26 142.96 18.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 O-C-N 121.577 -0.702 . . . . 0.0 109.585 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.66 157.96 57.13 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.859 3.04 . . . . 0.0 114.009 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 73.33 127.28 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 126.306 1.842 . . . . 0.0 108.496 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.27 176.89 2.53 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 123.587 0.755 . . . . 0.0 112.405 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.2 pt -66.29 121.04 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.025 0.917 . . . . 0.0 110.094 -171.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 30.2 ttp -94.87 124.4 38.89 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -75.14 128.78 36.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.192 0.996 . . . . 0.0 108.657 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -85.44 0.39 Allowed Glycine 0 CA--C 1.54 1.614 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.12 -159.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.5 mt -125.78 102.18 7.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.8 m -86.63 126.3 34.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.878 0.471 . . . . 0.0 109.807 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 p90 43.7 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 127.014 2.126 . . . . 0.0 112.087 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 124.578 2.132 . . . . 0.0 110.612 -176.526 . . . . . . . . 0 0 . 1 stop_ save_